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ABSTRACT 
THE EFFECTS OF SODIUM BICARBONATE SUPPLEMENTATION ON  
LOWER-BODY HYPERTROPHY-TYPE RESISTANCE EXERCISE 
by Benjamin McLean Carr 
May 2011 
 Introduction: A number of studies have demonstrated the ergogenic effects of 
induced-alkalosis on high-intensity intermittent exercise performance. Purpose: The aim 
of the present study was to examine the effects of sodium bicarbonate (NaHCO3) 
administration on a high-volume hypertrophy-type resistance exercise regimen for the 
lower body. Methods: In a double-blind counterbalanced manner, 12 resistance-trained 
male participants (mean ± SD; age = 20.3 ± 2 yr, mass = 88.3 ± 13.2 kg, height = 1.80 ± 
0.07 m), with a minimum of two years of training experience, ingested either 0.3 g·kg-1 of 
NaHCO3 or calcium carbonate (CaCO3) Placebo, divided into four even doses 
administered every 10 min, with the last dose being consumed approximately 60 min 
before the initiation of a hypertrophy-type resistance exercise (HRE) regimen for the 
lower body. The HRE protocol employed multiple exercises [back squat (SQ), inclined 
leg press (LP), and knee extension (KE)] utilizing four sets each, with 10- to12-RM (~65-
75% 1-RM) loads and short rest periods ranging from 60-90 s between sets. Exercise 
performance was determined by total repetitions generated during each exercise, 
repetitions accumulated throughout the exercise protocol, and a performance test (PT) 
involving a fifth set of KE to failure utilizing loads of approximately 50% 1 RM. 
Arterialized capillary blood samples were extracted via fingertip puncture at four time 
points and subsequently analyzed for pH, bicarbonate concentration ([HCO3-]), base 
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excess (BE), and lactate concentration ([Lac-]) by a portable clinical blood-gas analyzer. 
Results: Prior to exercise and relative to Placebo ingestion, NaHCO3 significantly 
elevated pH (mean ± SD; NaHCO3: 7.49 ± 0.02, Placebo: 7.42 ± 0.02, P < 0.05), [HCO3-] 
(NaHCO3: 31.50 ± 2.59, Placebo: 25.38 ± 1.78 mEq·l-1, P < 0.05), and BE (NaHCO3: 
7.92 ± 2.57, Placebo: 1.08 ± 2.11 mEq·l-1, P < 0.05). NaHCO3 administration resulted in 
significantly more total repetitions (SQ + LP + KE) than Placebo (NaHCO3: 139.8 ± 
13.2, Placebo: 134.4 ± 13.5), as well as significantly greater arterialized-capillary blood 
[Lac-] immediately after the exercise protocol (NaHCO3: 17.92 ± 2.08, Placebo: 15.55 ± 
2.50 mM, P < 0.05). There were no significant differences between group PT repetitions 
(NaHCO3: 23.8 ± 4.0, Placebo: 22.3 ± 3.7), although overall total repetitions (SQ + LP + 
NE + PT) remained significantly higher for the NaHCO3 condition (NaHCO3: 163.7 ± 
15.1 Placebo: 156.7 ± 14.5). Conclusions: Administration of 0.3 g·kg-1 NaHCO3 resulted 
in significantly more total repetitions accumulated throughout the exercise regimen. 
These findings demonstrate ergogenic efficacy for NaHCO3 administration during HRE 
and warrant further practical investigation into the effects of induced-alkalosis on the 
adaptations occurring during chronic HRE training.
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CHAPTER I 
INTRODUCTION 
Hypertrophy-Type Resistance Exercise 
Training with resistance exercise (e.g., weightlifting) has substantially increased 
in popularity over the past several decades. Individuals engage in resistance training for a 
variety of reasons, among those being to improve athletic performance, enhance general 
fitness, and to rehabilitate after injury (Fry, 2004). One of the most noticeable adaptations 
to chronic resistance training is an increase in skeletal muscle size, or hypertrophy (Bird, 
Tarpenning, & Marino, 2005). Muscle hypertrophy, which can be further defined as an 
increase in muscle cross-sectional area (Brooks, Fahey, White, & Baldwin, 2000), is of 
interest not only to athletes seeking to optimize performance, but also to individuals 
seeking improvements in body composition or increased capacity to perform the tasks of 
daily living (Bird et al., 2005). Skeletal muscle tissue is characterized by plasticity, with 
muscle readily adapting to imposed demands (Coffey & Hawley, 2007). Muscle 
hypertrophy is an adaptation that takes place when muscle must contract against 
increasingly heavier loads over time (Haddad & Adams, 2002). Training with 
progressively heavier loads, if done in the proper fashion, can lead to hypertrophy in both 
younger men (McCall, Byrnes, Dickinson, Pattany, & Fleck, 1996) and women (Kraemer 
et al., 2004), as well as older adults (Campbell, Crim, Young, & Evans, 1994). Exercise 
designed to enhance muscle growth will be referred to as hypertrophy-type resistance 
exercise (HRE) throughout this document. 
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HRE Regimen Design 
The specific muscular adaptations obtained through resistance exercise are 
dependent upon training program design. Resistance training programs that target muscle 
hypertrophy are distinctive from those programs that target muscular strength or 
endurance (Baechle, Earle, & Wathen, 2008). The American College of Sports Medicine 
(ACSM) has identified several acute variables associated with program design (ACSM, 
2009). Of primary interest here are the variables of exercise load, exercise volume, 
exercise selection, exercise order, and rest periods. 
Exercise load. A single bout of resistance exercise increases anabolic hormone 
concentrations, thereby potentiating the effects of hormone-tissue interaction (Crewther, 
Keogh, Cronin, & Cook, 2006). One of the most notable effects of this interaction is the 
muscle hypertrophy that accompanies resistance training. The proper design of a 
resistance training regimen is therefore essential in modulating the hormonal response 
and subsequent hypertrophy to exercise (Crewther et al., 2006). Muscle hypertrophy only 
occurs when there is a net protein accretion in which protein synthesis exceeds protein 
catabolism (Tipton & Wolfe, 2001). In order for muscle protein synthesis to occur, 
muscle must receive an adequate stimulus (Tipton & Wolfe, 2001). Without an adequate 
stimulus, the mechanisms responsible for muscle growth will function at a less than 
optimal capacity for maximizing hypertrophy (Spiering et al., 2008). Stimulus, or 
intensity, can be expressed in terms of exercise load. The load, which is possibly the most 
important design variable, is defined as the amount of weight lifted during each exercise 
set (Baechle et al., 2008). The appropriate load, or prescribed training intensity, is 
dependent upon the desired adaptation or training goal. Load is typically prescribed as a 
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percentage of the one-repetition maximum (1-RM)—the amount of weight that can be 
lifted only one time for a given exercise (e.g., 75% 1-RM). Load can also be prescribed 
as a multiple RM (Spiering et al., 2008). Multiple RM refers to the number of repetitions 
that can be completed until a point of momentary muscular failure or exhaustion (e.g., 5- 
RM). Repetition maximum values fall along a continuum and are related to specific 
training effects such as muscular endurance, strength, or power (Spiering et al., 2008).  
Skeletal muscle growth is directly related to motor-unit activation. Based on the 
size principle, the smaller motor units typically associated with type I muscle fibers are 
recruited first. As greater muscular force is needed to either maintain or increase work 
output, the larger type II motor units are increasingly recruited (Spiering et al., 2008). 
Since type II muscle fibers possess the greatest propensity for growth (McCall et al., 
1996), relatively heavy loads should be lifted to a point of momentary muscular failure to 
maximize hypertrophy (Spiering et al., 2008). For HRE, the load has traditionally been 
set at 8- to 12-RM, while strength and muscular endurance programs set the loads at 1- to 
6-RM and 15- to 25-RM, respectively (Fleck & Kraemer, 1988; Spiering et al., 2008). 
Failing to use an intensity that results in momentary muscular failure at approximately 10 
repetitions may not be stressful enough to create the metabolic and hormonal 
environment to induce hypertrophy (Linnamo, Pakarinen, Komi, Kraemer, & Hakkinen, 
2005). Setting the load at 8-12-RM increases total work output (Moss, Refsnes, 
Abildgaard, Nicolaysen, & Jenson, 1997) and maximizes the anabolic hormonal response 
(Gotshalk et al., 1997; Linnamo et al., 2005), ultimately creating the proper internal 
environment to facilitate hypertrophy (Kraemer et al., 1990). 
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Exercise volume. Exercise volume is the total amount of work performed during 
an exercise set or regimen and is typically expressed as total repetitions, calculated as 
number of sets multiplied by the number of repetitions performed in each set (Baechle et 
al., 2008). As with exercise load, total exercise volume affects the magnitude of the 
anabolic hormone response. Even though single-set exercises have been shown to induce 
hypertrophy in untrained individuals, multiple-set, higher volume regimens appear to be 
superior for stimulating greater hypertrophy, especially as resistance training experience 
advances (Ronnestad et al., 2007). A HRE regimen, with a relatively high number of sets 
and total repetitions, elicits the greatest growth hormone response (Gotshalk et al., 1997). 
Growth hormone, which is actually comprised of a family of anabolic polypeptide 
hormones, is a potent anabolic agent and is highly sensitive to resistance exercise loads 
and overall volume. Hypertrophy schemes have elicited a growth hormone concentration 
that is, on average, eight times higher than that seen with power or strength schemes 
(Crewther et al., 2006). Lactate accumulation is thought to be one of the stimulators of 
growth hormone secretion (Gordon, Kraemer, Vos, Lynch, & Knuttger, 1994). It has 
been shown that, with regard to resistance exercise, the largest increase in lactate 
concentration is seen with exercise regimens that have the greatest volume (Linnamo et 
al., 2005). There is also a possible link between lactate accumulation and elevated 
testosterone concentration, which further suggests that HRE regimens are effective in 
eliciting the hormonal environment necessary for muscle growth (Lu et al., 1997). 
Rest periods. Another important determinant of the hypertrophic response to 
resistance exercise is the length of the rest periods. Rest period, which can be defined as 
the time between exercise sets or exercises, is related to exercise intensity and is 
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dependent upon training goals (Bird, et al., 2005). Rest period length has a significant 
effect on resistance exercise-induced adaptations (Spiering et al., 2008). For hypertrophy 
development, shorter rest periods lead to larger increases in total work output and 
circulating anabolic hormones (Kraemer, Noble, Clark, & Culver, 1987). For this reason, 
it is often recommended that HRE regimens have rest periods ranging from one to two 
minutes (Bird et al., 2005). Some research suggests that even shorter rest periods of 30-
60 seconds (s) may be optimal (de Salles et al., 2009). However, while shorter rest 
periods may be advantageous for novice or intermediate lifters, more advanced lifters 
may need approximately one to three minutes, depending on exercise type and intensity, 
with multi-joint, large musculature exercises typically requiring the greatest amount of 
rest between sets (ACSM, 2009). In general, though, the shorter rest periods utilized with 
hypertrophic schemes (e.g., one minute between sets) are superior to the longer rest 
periods seen with strength and power schemes (e.g., three to five minutes between sets) 
in terms of facilitating muscle growth (de Salles et al., 2009).  
 Exercise selection and order. Two final important acute design variables are 
exercise selection and exercise order. Exercise selection refers to the process of choosing 
those exercises that will be included in a resistance training regimen (Baechle et al., 
2008). Exercises may be classified as single-joint or multi-joint, with the latter involving 
two or more joints and requiring greater muscular effort (Bird et al., 2005). Exercises that 
utilize large muscle groups, such as the back squat, significantly invoke those hormonal 
and metabolic processes necessary for muscle growth (Spiering et al., 2008). Even 
though multi-joint exercises require greater muscle mass, both multi- and single-joint 
exercises can promote hypertrophy and are both typically included in resistance training 
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regimens (Bird et al., 2005). Exercise order, or the sequence of exercises performed 
within an exercise session, should typically progress from exercises involving the more 
energetically demanding larger musculature to less demanding exercise involving smaller 
musculature (Hickson, Buono, Wilmore, & Constable, 1984). Multi-joint exercise 
performance declines when these exercises are performed later in an exercise regimen; 
therefore, exercises involving multiple joints and large musculature should be performed 
at the beginning of the resistance exercise session (Spreuwenberg et al., 2006). 
Performing large musculature, multi-joint exercises at the beginning of a training session 
also maximizes the total work output over the entire exercise session (Sforzo & Touey, 
1996) and elevates anabolic hormone concentrations, potentiating hormone-tissue 
interaction for exercises occurring later in the session (Bird et al., 2005). 
 Summary. Hypertrophy-type resistance exercise regimens are characterized by 
moderate loads, short rest periods, and high total volume. Exercise loads should be set at 
approximately 8-12-RM, with rest periods of approximately one minute between sets. 
Performing multiple sets of an exercise is superior to a single set, with greater total 
exercise volumes eliciting greater concentrations of the anabolic hormones. Both single- 
and multi-joint exercises may be performed, with the multi-joint, large musculature 
exercises being performed at the beginning of the exercise session. 
Fatigue During HRE 
Typical HRE regimens, as detailed above, can be classified as high-intensity, 
intermittent exercise, characterized by heavy periods of activity interspersed with brief 
rest periods. The fatigue associated with this type of exercise (i.e., brief intervals of 
maximal effort) is likely to be multi-faceted (Lambert & Flynn, 2002). Fatigue, which 
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can be defined as a reduction in muscular force producing capabilities, is associated with 
both central and peripheral factors (Boerio, Jubeau, Zory, & Maffiuletti, 2005). However, 
the primary site of fatigue during intense exercise appears to be peripheral, occurring 
within the muscle cell, or fiber (Fitts, 1994). 
Sources of Fatigue 
Hypertrophy-type resistance exercise is intense and prolonged. For example, 
bodybuilders seeking to maximize hypertrophy may perform anywhere from 15 to 20 sets 
of exercises for one muscle group, with limited recovery between sets (Lambert & Flynn, 
2002). As previously stated, the fatigue during this type of resistance exercise is multi-
faceted, and the specific cause of fatigue is often difficult to elucidate. During intense 
exercise, multiple energy substrates are depleted with the concurrent accumulation of 
metabolites, making it difficult to determine if energy depletion or metabolic 
intermediate/end-product accumulation is the primary cause of fatigue. For example, 
during intense exercise, phosphocreatine (PCr) and glycogen are depleted  (Lambert & 
Flynn, 2002), while hydrogen ions and adenosine diphosphate (ADP) accumulate (Miller, 
Boska, Moussavi, Carson, & Weiner, 1988). Resistance exercise confounds the problem 
since the source of fatigue during the first set of 10 repetitions to muscular failure is 
likely different from the primary source of fatigue during the later exercise sets (Lambert 
& Flynn, 2002).  
Substrate depletion. The primary contributors to fatigue during HRE are thought 
to be PCr and glycogen depletion and metabolic acidosis (Lambert & Flynn, 2002), 
although more recent evidence suggests that the accumulation of inorganic phosphate (Pi) 
that accompanies rapid adenosine triphosphate (ATP) hydrolysis may play a more 
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significant role than previously thought (Mougios, 2006). PCr serves as an important 
immediate source of ATP replenishment, but due to limited supplies, PCr stores are 
significantly reduced in a matter of seconds during high-intensity exercise. This substrate 
depletion is highly correlated with fatigue (Sahlin, Tonkonogi, & Soderlund, 1998), 
especially after one, 10-RM set of resistance exercise (Lambert & Flynn, 2002). 
MacDougall et al. (1999) established that total muscular force-producing capacity was 
reduced only 20% following one set approaching momentary muscular failure 
(approximately 12-RM). This suggests that one maximal set of exercise fatigues the 
muscle, but does not exhaust it. According to an analysis by Lambert & Flynn (2002) of 
the MacDougall et al. study (1999), the energy to complete one, 12-RM set was derived 
as follows: 1.6% from stored ATP, 16.3% from PCr hydrolysis, and 82.1% from 
glycolysis (or glycogenolysis). The large contribution from glycolysis can be explained 
by the fact that PCr hydrolysis can only sustain maximal activity for approximately 10 s 
(Cramer, 2008), and resistance exercise sets of approximately 12 repetitions may last 35-
40 s (Lambert & Flynn, 2002). Larger contributions from anaerobic glycolysis are 
necessary to sustain near maximal exercise for this length of time (Matson & Tran, 1993). 
Lambert and Flynn (2002) suggest that glycogen depletion could be a source of 
fatigue during repeated bouts of very intense exercise due to preferential utilization of 
type II muscle fibers during HRE. Glycogen concentration is substantially higher in type 
II fibers, and the rate of glycogenolysis in type II fibers has been reported as being 62% 
faster than the rate in type I fibers during 30 s of maximal treadmill sprinting (Greenhaff 
et al., 1994). When analyzing single muscle fibers following biopsy, Nicholas et al. 
(1999) found that glycogen was more significantly depleted in type II fibers, in 
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comparison to type I fibers, following a high-intensity intermittent exercise protocol. 
Research has shown that one elbow flexor exercise set at approximately 12-RM (80% 1- 
RM) resulted in a 12% decrease in glycogen concentration of the biceps brachii, while 
three sets at 80% 1-RM resulted in a 24% decrease in glycogen concentration 
(MacDougall et al., 1999). Similar research has shown that one set of leg extensions at 
70% 1-RM (~12-13 repetitions) resulted in a 26.1% decrease in glycogen content of the 
vastus lateralis, with six sets resulting in a 38% decrease in glycogen (Robergs et al., 
1991). Although the study by Greenhaff et al. (1994) indicated heavy reliance on type II 
fiber glycogenolysis during maximal sprinting, significant glycogen stores still remained 
after the 30 s of activity. This 30-s bout of maximal activity is akin to one set of 
resistance exercise taken to momentary muscular failure. Taken together, these studies 
suggest that, while glycogen depletion is not a source of fatigue during one set of 
maximal activity, glycogen depletion could become a source of fatigue during repeated 
bouts of very intense exercise (Lambert & Flynn, 2002). 
 Acidosis. Having established that glycolysis is a major source of ATP production 
during HRE, the focus now turns to acidosis-related fatigue. The glycolysis primarily 
involved during high-intensity resistance training is termed anaerobic, or fast, glycolysis 
and results in lactate production (Cramer, 2008). As the body relies heavily on anaerobic 
glycolysis for ATP, there are large increases in intracellular hydrogen ion (H+) and lactate 
concentrations (acidosis) (Medbo & Tabata, 1993). This glycolysis-coupled H+ 
production has historically been thought to be the greatest contributor to metabolic 
acidosis (Juel, 1998). However, this line of reasoning has drawn criticism, with some 
researchers suggesting that the extensive ATP hydrolysis occurring during muscle 
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contraction is the major source of H+ (Robergs, Ghiasvand, & Parker, 2004). Whatever 
the case may be, high-intensity exercise is strongly associated with increasingly acidic 
intra- and extracellular pH, and this acidosis is often implicated as a major source of 
fatigue (Materko, Santos, & Novaes, 2008; Sahlin et al., 1998). 
 Acidosis mechanisms of fatigue. There are several mechanisms by which acidosis, 
or H+ accumulation, is suspected to contribute to fatigue. Acidosis reduces actomyosin 
ATPase activity, which in turn likely reduces cross-bridge turnover rates (Allen, 
Westerblad, & Lannergren, 1995). This interference in actin-myosin coupling has been 
shown to reduce muscle force generating capacity (Spriet, Matsos, Peters, Heigenhauser, 
& Jones, 1985). There may also be a reduced affinity of troponin for calcium (Ca2+) due 
to competitive H+ interference, which would reduce force generating capacity as well 
(Chin & Allen, 1998). Excessive H+ is also associated with disturbances in normal Ca2+ 
and potassium (K+) activity within the muscle fiber. Acidosis appears to interfere with 
both Ca2+ release and sequestering by the sarcoplasmic reticulum (Fitts, 1994), and this 
interference in Ca2+ equilibrium is thought to contribute to the development of fatigue 
(Mougios, 2006). In terms of K+ equilibrium, acidosis is associated with an efflux of K+ 
from the cell, which could reduce sarcolemma excitability and, consequently, muscle 
fiber force production (Broch-Lips, Overgaard, Praetorius, & Nielsen, 2007). Excessive 
H+ may also interfere with ATP-generating processes. Acidosis inhibits glycolysis, likely 
through the inhibition of phosphofructokinase activity (Sutton, Jones, & Toews, 1981). 
Acidosis also interferes with creatine kinase equilibrium, which could reduce the rate of 
ATP resynthesis (Sahlin et al., 1998). These effects of H+ accumulation are likely key 
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contributors to the muscular fatigue, or reduction in force producing capabilities, 
experienced during HRE. 
Attenuating Acidosis 
 As acidosis can be detrimental to cellular functioning, the body needs 
mechanisms to remove excessive H+. Resting intracellular pH is slightly alkaline, with an 
approximate value of 7.2 (Juel, 1998, 2008). Resting extracellular pH is slightly more 
alkaline at approximately 7.4 (Juel, 2008). Although the human body is fairly resistant to 
large fluctuations in pH, intense exercise may result in a decrease in intra- and 
extracellular pH to approximately 6.5 and 6.9, respectively (Coombes & McNaughton, 
1993). Since pH is calculated as the negative logarithm of the H+ concentration, a 
decrease in 1.0 pH unit represents a ten-fold increase in hydrogen ions (McNaughton, 
2002). To attenuate the accumulation of H+, the body employs several H+ transport and 
buffer systems. While buffers “tie up” H+, transporters move H+ between intra- and 
extracellular compartments. The two most quantitatively important transporters for H+ 
removal are the Na+/H+ exchangers and lactate/H+ co-transporters, with the latter serving 
a more important role during high-intensity exercise (Juel, 2008). 
Buffers. The presence of a buffer in a system allows for more acid (H+) to be 
added to that system before affecting a change in pH (Juel, 2008). The buffering of acids 
to maintain physiologic pH can be referred to as acid-base balance. There are three 
primary buffer systems utilized by the body to maintain acid-base balance: respiratory, 
renal and chemical (Guyton & Hall, 1996). The respiratory mechanisms comprise the 
second line of defense against acidosis, acting in a couple of minutes to attenuate acidosis 
by removing carbon dioxide (CO2), while the renal system is the last line, slowly 
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correcting acidosis through the secretion of acidic urine (Guyton & Hall, 1996). The 
chemical buffers are the first line of defense against acidosis, reacting within a fraction of 
a second, and are the focus of the present study. The chemical buffers are comprised of 
proteins (e.g., hemoglobin and albumin), small peptides (e.g. carnosine), dibasic Pi, and 
bicarbonate (Juel, 2008; Sahlin, Alvestrand, Brandt, & Hultman, 1978). While 
hemoglobin and plasma proteins are quantitatively important extracellular buffers 
(Medbo, Noddeland, & Hanem, 2009), the bicarbonate system is regarded as the most 
important extracellular buffering system for maintaining acid-base balance (Guyton & 
Hall, 1996). Indeed, bicarbonate has been shown to buffer approximately 62% of the 
hydrogen ions released to blood during exhaustive cycling (Medbo et al., 2009). The 
bicarbonate system is depicted below (McNaughton, Siegler, & Midgley, 2008): 
  H+ + HCO3- ↔ H2CO3 ↔ CO2 + H2O 
Bicarbonate. In the above reversible reaction, H+ combines with the bicarbonate 
ion (HCO3-) to produce carbonic acid (H2CO3), which readily dissociates into CO2 and 
water (H2O) (Guyton & Hall, 1996). Simplistically, the CO2 generated travels through the 
blood and is eliminated at the level of the lungs, effectively eliminating H+ from the 
system (McNaughton et al., 2008). Whether or not intracellular acidosis occurs as a result 
of H+ accumulation is dependent upon the rates of H+ production and removal (Roussel et 
al., 2003). The intra- and extracellular buffer systems, as well as the H+ transport 
systems, work to reduce the build-up of the free H+ that occurs during high-intensity 
exercise (Bishop, Edge, Davis, & Goodman, 2004). Efflux of H+ from the cell to the 
extracellular fluids depends on the H+ concentration both inside and outside of the cell. 
While acidosis of the extracellular fluids inhibits the efflux of H+ from the cell 
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(Mainwood & Worsley-Brown, 1975), an increase in extracellular HCO3- creates a pH 
gradient that promotes H+ efflux, subsequently attenuating reductions in intracellular pH 
(McNaughton et al., 2008). Given that excessive H+ appears to have deleterious effects 
on muscle cell functioning, researchers have taken interest in methods to elevate the pH 
gradient between the intra- and extracellular environments. Since HCO3- does not readily 
permeate the sarcolemma (Mainwood & Cechetto, 1980), much of the research has 
centered on elevating extracellular HCO3- concentrations (McNaughton et al., 2008). 
Historically, most attempts to elevate extracellular HCO3- concentrations have utilized 
sodium bicarbonate (NaHCO3) supplementation (Webster, 2002). 
Summary. The fatigue experienced during high-intensity, intermittent exercise, 
such as HRE, likely has multiple sources. Anaerobic glycolysis provides the majority of 
the ATP for muscle contraction during a set of HRE. In conjunction with extensive ATP 
hydrolysis, extensive anaerobic glycolysis generates excessive H+. An accumulation of 
H+, and the consequent drop in pH, inhibits muscle force production. There are various 
proposed mechanisms of this fatigue, such as interference with the excitation-contraction 
coupling processes and inhibition of energy producing reactions. The human body is 
equipped with mechanisms to attenuate excessive H+, among those being H+ transporters 
and intra- and extracellular buffers. The bicarbonate system is the most important 
chemical extracellular buffer, correcting for decreases in pH in a fraction of a second. 
Elevation of extracellular HCO3- creates a pH gradient and facilitates efflux of H+ from 
the muscle fiber. This attenuation of acidosis can prevent or minimize the deleterious 
effects of H+ accumulation and potentially enhance exercise. The most common means of 
elevating extracellular HCO3- has been NaHCO3 supplementation. 
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CHAPTER II 
REVIEW OF LITERATURE 
Ergogenic Effects of Sodium Bicarbonate 
Interest in attenuating exercise-induced acidosis as a means of exercise 
performance enhancement in humans spans nearly ten decades, with some of the initial 
alkalosis-related research being conducted in the early 1930s  (Dennig, Talbot, Edwards, 
& Dill, 1931; Dill, Edwards, & Talbot, 1932). The modern era of research in NaHCO3 
supplementation began in the late 1970s and continues today. A number of reviews are 
available to help sift through the extensive NaHCO3 supplementation data (Linderman & 
Gosselink, 1994; Matson & Tran, 1993; McNaughton, 2002; McNaughton et al., 2008; 
Requena, Zabala, Padial, & Feriche, 2005; Webster, 2002).  This review of literature will 
primarily focus on a subset of the NaHCO3 literature, namely those studies examining the 
effect of NaHCO3 supplementation on high-intensity, intermittent exercise (HIE). 
However, before delving into those specific HIE studies, some of the extensive 
information contained in previous studies and reviews will be synthesized where 
appropriate. 
NaHCO3 Supplementation 
 NaHCO3 (i.e., baking soda) is an alkalizing salt that dissociates into sodium (Na+) 
and HCO3- when dissolved in solution (Wear, McPherson, & Kolling, 2010). NaHCO3, 
whether administered intravenously or orally, has been shown to elevate the HCO3- 
reserve in the blood (Maughan et al., 1986; Price et al., 2003; Siegler & Hirscher, 2010; 
Webster et al., 1993). This increase in extracellular HCO3- concentration is the primary 
rationale behind NaHCO3 administration for attenuation of acidosis, since a more alkaline 
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extracellular environment creates a pH gradient and facilitates H+ efflux (Aschenbach et 
al., 2000; Stephens, McKenna, Canny, Snow, & McConell, 2002). This increase in H+ 
efflux is likely due to the activity of the lactate/H+ co-transporter, which is upregulated in 
response to an increasing pH gradient (Roth, 1991).  It has also been postulated that the 
Na+ resulting from the NaHCO3 dissolution has possible ergogenic, or performance 
enhancing, effects as well (Mitchell et al., 1990). The potential benefits are attributed to 
an increase in plasma volume and tissue perfusion due to the Na+ load (Mitchell et al., 
1990), an increase in H+ efflux due to upregulation of the Na+/ H+ exchanger (Bishop et 
al., 2004), or an elevation of extracellular HCO3- due to disturbances in strong ion 
equilibrium (Heigenhauser & Jones, 1991). Whether Na+ confers any ergogenic effects is 
equivocal (Aschenbach et al., 2000; Kozak-Collins, Burke, & Schoene, 1994), and Na+ 
currently remains a component of a commonly used placebo sodium chloride (NaCl) in 
NaHCO3 research (Price & Simmons, 2010; Siegler & Hirscher, 2010).   
 Alkalizing agents. NaHCO3 has been used to induce alkalosis in numerous studies 
utilizing a variety of exercise modes. For example, the effects of NaHCO3 administration 
have been examined with treadmill sprinting (van Montfoort, van Dieren, Hopkins, & 
Shearman, 2004), competitive running (Goldfinch, McNaughton, & Davies, 1988; 
Wilkes, Glendhill, & Smyth, 1983), cycle ergometry (Stephens et al., 2002), arm 
ergometry (Aschenbach et al., 2000), swimming (Zajac, Cholewa, Poprzecki, 
Waskiewicz, & Langfort, 2009), rowing (Brien & McKenzie, 1989), rhythmic hand-
gripping (Nielsen, Hein, Svendsen, Secher, & Quistorff, 2002), interval training (Edge, 
Bishop, & Goodman, 2006), resistance exercise (Webster, Webster, Crawford, & 
Gladden, 1993; Portington et al., 1998), judo (Artioli et al., 2007), boxing (Siegler & 
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Hirscher, 2010), water polo (Tan et al., 2010), and other sport-specific performance tests 
(Bishop & Claudius, 2005; Wu, Shih, Yang, Huang, & Chang, 2010). Although NaHCO3 
is the most frequently utilized alkalosis-inducing ergogenic aid (Requena et al., 2005), 
NaHCO3 is not the only alkalizing agent that has been used in exercise-related research. 
Sodium salts of citrate (Potteiger, Nickei, Webster, Haub, & Palmer, 1996; van Someren 
et al., 1998), acetate (Smith, Jeukendrup, & Ball, 2007), and lactate (van Montfoort et al., 
2004) have all been used to induce alkalosis. Next to NaHCO3, sodium citrate (Na-
citrate) has been the most prevalently used aid to attenuate acidosis (McNaughton & 
Cedaro, 1992; Oopik, Saaremets, Medijainen, Karlson, Janson, & Timpmann, 2003; 
Parry-Billings & MacLaren, 1986). Although studies have shown Na-citrate to elevate 
pH and extracellular HCO3- (Parry-Billings & MacLaren, 1986; van Someren et al., 
1998), evidence of enhanced buffering and performance is lacking (Robergs, 2002). The 
exact mechanisms of Na-citrate-induced alkalosis have yet to be elucidated, with the 
hypothesis of electrical equilibrium disturbances gaining recent support (Requena et al., 
2005; Robergs, 2002). However, some research suggests that the chemical properties of 
citrate inherently make it a poor blood buffer (Robergs, 2002). Along these lines, van 
Someren (1998) found that Na-citrate is not an effective ergogenic aid for HIE, a form of 
exercise that results in the excessive accumulation of H+ (Matson & Tran, 1993). On the 
other hand, numerous studies utilizing NaHCO3 administration have shown strong 
ergogenic potential for protocols involving HIE (Requena et al., 2005); therefore, 
NaHCO3 will remain the focus here. 
  NaHCO3 reviews. Resistance exercise, especially HRE, falls under the broader 
genre of HIE (Lambert & Flynn, 2002). The effects of NaHCO3 administration have been 
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examined on a variety of exercise types, including HIE. While many past NaHCO3 
investigations have produced equivocal results (Linderman & Gosselink, 1994), several 
recent reviews elucidate the effects of NaHCO3 on different types of exercise 
(McNaughton et al., 2008; Requena et al., 2005; Webster, 2002). Webster (2002) divided 
NaHCO3 studies into four general types based on duration and intensity of exercise—
power, anaerobic, oxidative, and interval. Along these same lines, Requena et al. (2005) 
and McNaughton et al. (2008) grouped studies based on exercise characteristics. Requena 
et al. (2005) grouped studies that utilized high-intensity, short-term exercise (< 120 s), 
those that contained repeated-bout protocols, and those involving high-intensity, long 
term exercise (> 120 s). Similar to this method, McNaughton et al. (2008) divided studies 
into the following three groups: high-intensity exercise, prolonged continuous exercise, 
and prolonged intermittent exercise. According to Webster (2002), power exercises last 
from three to 30 s and rely heavily on the phosphagen system. The author indicates that 
there is little rationale or supporting literature for NaHCO3 use during this type of 
exercise (Webster, 2002). Requena et al. (2005) are in agreement, suggesting that 
exercise of insufficient duration is not enhanced due to minimal acid-base disturbances. 
The most consistently examined exercise type relative to NaHCO3 supplementation has 
been anaerobic exercise (McNaughton et al., 2008; Webster, 2002). Webster (2002) 
defines anaerobic exercise as maximal exercise lasting one to seven minutes. Well 
designed and controlled studies examining the effects of NaHCO3 supplementation for 
this type of exercise have been some of the most consistent in demonstrating an 
ergogenic effect (Matson & Tran, 1993; Webster, 2002). Less consistent are the effects 
seen with prolonged endurance, or aerobic, performance (McNaughton et al., 2008; 
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Webster, 2002). Aerobic exercise is defined as submaximal or maximal exercise lasting 
at least 10 minutes (min) in duration (Webster, 2002). Although most early investigations 
into the effects of induced-alkalosis on aerobic performance indicated no effects 
(Webster, 2002), recent studies have indicated ergogenic potential, making the results 
difficult to interpret (McNaughton et al., 2008).  
 NaHCO3 and HIE. The last exercise type identified by Webster (2002) is interval 
exercise, characterized by repeated bouts of activity with relatively short rest periods 
between bouts. This type of exercise, which may also be referred to as repeated-bouts 
exercise (Requena et al., 2005) or prolonged intermittent exercise (McNaughton et al., 
2008), includes resistance exercise. As noted by Lambert and Flynn (2002), a source of 
fatigue during HRE is the acidosis that occurs due to extensive anaerobic glycolysis. 
While there is evidence to suggest that NaHCO3 supplementation may be beneficial to 
intermittent exercise such as HRE (Webster, 2002), there have been relatively few studies 
conducted examining the effects of an alkalizing agent on resistance exercise. Only six 
published studies have been identified that examine the effects of induced-alkalosis on 
some type of resistance exercise (Coombes & McNaughton, 1993; Materko et al., 2008; 
Maughan, Leiper, & Litchfield, 1986; Portington et al., 1998; Verbitsky, Mizrahi, Levin, 
& Isakov, 1997; Webster et al., 1993). Since resistance exercise is a form of HIE, results 
from studies examining other HIE modes can be extrapolated to HRE (Lambert & Flynn, 
2002). As such, this review focuses on the effects of NaHCO3 supplementation on HIE. 
Twenty-nine studies, spanning four decades, were selected for more extensive review 
based on the following criteria: NaHCO3 must have been used as the alkalizing agent; 
NaHCO3 must have been administered orally; and the research protocol must have 
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involved HIE (i.e., intervals, with minimal rest periods) or resistance exercise. Table 1 
summarizes the selected studies, with special emphasis on supplementation and exercise 
protocols and performance results. These emphases will be further detailed below. 
Supplementation Protocols 
Dosage. Before discussing dosing protocols of the selected HIE studies, a 
preliminary examination of other research is warranted. A dosage of 0.3 grams per 
kilogram of body mass (g·kg-1) has been the most frequently administered dose of 
NaHCO3 (Webster, 2002), with this amount being based, at least in part, on previous 
research. Horswill et al. (1988) examined the dose-response relationship of NaHCO3 
supplementation on cycle sprints by administering doses of 0.1, 0.15, and 0.2 g·kg-1. 
Although performance was not enhanced, the authors found that all doses significantly 
elevated plasma HCO3-, with 0.2 g·kg-1 having the greatest effect. While all three doses 
elevated pH over placebo, there were no differences between groups. It is interesting to 
note that most significant elevations in pH are in the range of 0.05 to 0.1 units above 
resting values, and these elevations are not always strongly correlated with dosage 
(Webster, 2002). McNaughton (1992) examined the effects of doses ranging from 0.1 to 
0.5 g·kg-1 on 60-s cycle ergometry performance. In contrast to Horswill et al. (1988), 
McNaughton found no effect of 0.1 g·kg-1 on pH or HCO3- concentrations. However, 
McNaughton (1992) did find that dosages of 0.2, 0.3, 0.4, and 0.5 g·kg-1 significantly 
elevated pH and HCO3-. Doses of 0.3 g·kg-1 and above increased peak power output, but 
there was no additional increase beyond the 0.3 g·kg-1 dose.  
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Table 1 
Summary of Studies Examining the Effects of NaHCO3 Supplementation on High-Intensity Intermittent Exercise 
 
Author Participants Supplementation Dosage Timing Exercise Protocol Performance Results 
Costill et al. 
(1984) 
10 males, 1 
female; age = 
32.4 years 
0.2 g·kg-1 NaHCO3 in 400 ml 
solution consumed over 5-minute 
period; 1 g NaCl placebo 
60 minutes prior to 
exercise testing 
4 x 60-second cycling 
bouts; 60-second rest 
periods between bouts; 
performance test: 5th cycling 
bout to fatigue 
Performance test time to 
fatigue increased by 47 
seconds (42% increase) 
McKenzie et 
al. (1986) 
6 male athletes; 
age = 22 ± 1.6 
years 
0.3 g·kg-1 NaHCO3 or 0.15 g·kg-1 
NaHCO3 in 400 ml solution; 
placebo (no details) 
60 minutes prior to 
exercise testing 
5 x 60-second cycling 
bouts; 60-second rest 
periods between bouts; 
performance test: 6th cycling 
bout to fatigue 
Both NaHCO3 trials 
increased work output and 
performance trial time, with 
no significant difference 
between trials 
Parry-
Billings and 
MacLaren 
(1986) 
 
 
6 healthy male 
participants; no 
age data 
presented 
0.3 g·kg-1 NaHCO3 or 0.3 g·kg-1 
Na-citrate or 0.3 g·kg-1 NaHCO3/ 
Na-citrate ingested in a flavored 
soup over 5- to 10-minute period; 
NaCl placebo 
150 minutes prior to 
exercise testing 
3 x 30-second maximal 
cycling sprits; 6-minute rest 
period between sprints 
No increase in sprint 
performance; trend was 
present for elevated peak and 
mean power 
Maughan et 
al. (1986) 
10 physically 
active males; age 
= 27 ± 5 years  
0.3 g·kg-1 NaHCO3 (alkalosis), 
NH4Cl (acidosis), or CaCO3 
(control); consumed in 1-2 gram 
doses over 150-minute period; 
water consumed ad libitum  
Exercise testing 
commenced 
approximately 180 
minutes after first 
dose 
Sustained knee extensor 
MVC percentages (80%, 
50%, 20%) to failure; 5- 
minute rest periods between 
sustained contractions  
Alkalosis increased muscular 
endurance capacity at 20% 
MVC; acidosis decreased 
endurance capacity at 50% 
and 20% MVC 
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Table 1 (continued). 
 
Author Participants Supplementation Dosage Timing Exercise Protocol Performance Results 
Gao et al. 
(1988) 
10 male collegiate 
swimmers; age = 
20 ± 0.5 years 
2.9 mmol/kg NaHCO3 (~0.24 
g·kg-1) dissolved in 300 ml 
solution; 17 mmol NaCl (~1 g) 
placebo 
 
Approximately 73 
minutes prior to exercise 
testing 
5 bouts of maximal front crawl 
swimming; 2-minute rest 
periods between bouts 
Bouts 4 and 5 were 
significantly faster 
Lavender 
and Bird 
(1989) 
8 healthy females; 
15 healthy males; 
ages 18-28 
0.3 g·kg-1 NaHCO3 in 400 ml 
solution; 8 g NaCl placebo 
200 ml of solution 120 
minutes pre trial; 
remaining 200 ml 60 
minutes pre trial 
 
10 x 10-second  maximal 
cycling sprints; 50-second rest  
period between sprints 
Increase in average 
power and peak power 
values 
Gaitanos et 
al. (1991) 
7 healthy males; 
age = 24.0 ± 1.9 
years 
0.3 g·kg-1 NaHCO3 in 500 ml 
solution; consumed over 10 
minutes; 1.5 g NaCl placebo 
 
150 minutes  prior to 
exercise testing 
10 x 6-second maximal sprints 
on non-motorized treadmill 
Trend for higher mean 
and peak power output 
and work done, but 
results not significant 
Webster et 
al. (1993) 
6 resistance-
trained males; age 
= 19.7 ± 0.5 years 
0.3 g·kg-1 NaHCO3 in gelatin 
capsules taken in single bolus; 
water consumed ad libitum; 
white flour placebo 
 
105 minutes prior to 
exercise testing 
4 sets of 12 repetitions at 70%  
1-RM on leg press exercise; 5th 
set to muscular failure at 70% 1-
RM; 90-second rest periods 
between sets 
4 of 6 participants 
increased repetitions in 
5th set, but results not 
significant 
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Table 1 (continued). 
 
Author Participants Supplementation Dosage Timing Exercise Protocol Performance Results 
Coombes and 
McNaughton 
(1993) 
9 recreationally 
active males; age = 
21.2 ± 2.6 years 
0.3 g·kg-1 NaHCO3 in 400 ml of 
low caloric liquid; 0.3 g·kg-1 
CaCO3 placebo  
Approximately 90 
minutes prior to 
exercise testing 
2 sets of isokinetic leg 
extension/flexion; set 1 = 4 
repetition strength; set 2 = 60 
repetition endurance; rest = 5 
minutes between sets 
 
Increase in total work 
and peak torque 
Kozak-Collins 
et al. (1994) 
7 competitive female 
cyclists acclimatized 
to elevation; age = 
26 ± 3 years 
0.3 g·kg-1 NaHCO3 in 8-13 
gelatin capsules; consumed 
over 15-minute period; water 
consumed ad libitum; 0.207 
g·kg-1 NaCl
 
placebo 
 
120 minutes prior 
to exercise testing 
1-minute cycling sprints at 95% 
VO2max; 1- minute rest between 
sprints; sprints continued until 
participant could not complete a 
full 1-minute sprint; testing was at 
moderate altitude 
 
Completed more total 
intervals, but  results 
not significant 
Verbitsky et al. 
(1997) 
6 recreationally 
active males; age = 
36.5 ± 6 years 
0.4 g·kg-1 NaHCO3 during 
experimental condition only 
60 minutes prior to 
exercise testing 
Pre-load: e-stim isometric 
quadriceps contractions for 2 
minutes; 3-minute supra-maximal 
loading on cycle ergometer; 3-
minute rest periods; Post-load: 
repeat pre-load 
 
Increased post-load 
peak torque and residual 
torques 
Portington et 
al. (1998) 
15 resistance-trained 
males; age = 21.5 ± 
0.4 years 
0.3 g·kg-1 NaHCO3 in gelatin 
capsules consumed in 5-minute 
period; water consumed ad 
libitum; white flour placebo 
105 minutes prior 
to exercise testing 
5 sets of leg presses at 
approximately 12-RM; 90- 
second rest periods between sets  
7 of 15 participants 
increased total 
repetitions, but results 
not significant 
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Table 1 (continued). 
 
Author Participants Supplementation Dosage Timing Exercise Protocol Performance Results 
Aschenbach et 
al. (2000) 
8 male collegiate 
wrestlers; age = 
20.6 ± 0.8 years 
0.3 g·kg-1 NaHCO3 or 0.21 g·kg-
1
 NaCl in 0.2 molar low-calorie 
drink; low-calorie drink (no salt 
added) placebo 
Equal volumes of 
solution consumed 
90 and 60 minutes 
prior to exercise 
testing 
 
8 x 15-second maximal arm 
ergometry bouts; 20-second 
freewheel pedaling recovery 
periods between bouts 
No differences seen in 
peak power or total 
work 
McNaughton 
et al. (2000) 
6 males, 2 females; 
age = 22.5 ± 1.15 
years 
0.5 g·kg-1 NaHCO3 contained in 
gelatin capsules; divided into 4 
doses per day 
Chronic dosing for 5 
days; exercise testing 
took place on the 6th 
day 
 
3 x 30-second maximal cycling 
sprints 
Increased total work 
output (sprints 1 and 2) 
and peak power output 
(sprints 1 and 2) 
Price et al. 
(2003) 
8 moderately-
trained males; age = 
25.4 ± 6.4 years 
0.3 g·kg-1 NaHCO3 drink; 0.045 
g·kg-1 NaCl placebo 
60 minutes prior to 
exercise testing 
10 x 3-minute blocks on cycle 
ergometer: 90-seconds at 40% 
VO2max; 60-seconds at 60% 
VO2max; maximal sprint; 14-
second active recovery  
 
Power output was 
maintained at a level 
similar to the initial 
stages of exercise  
Bishop et al. 
(2004) 
10 recreationally-
active females; age 
= 19 ± 1 years 
0.3 g·kg-1 NaHCO3 contained in 
8-14 gelatin capsules; consumed 
with 500 ml of water 0.207 g·kg-
1
 NaCl placebo 
90 minutes prior to 
exercise testing 
5 x 6-second maximal sprints on 
cycle ergometer; 24-second rest 
period between sprints 
Increased total work and 
peak power output, 
primarily during sprints 
3-5 
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Table 1 (continued). 
 
Author Participants Supplementation Dosage Timing Exercise Protocol Performance Results 
Bishop 
and 
Claudius 
(2005) 
7 team-sport 
female athletes; 
age = 19 ± 1 
years 
2 x 0.2 g·kg-1 NaHCO3 contained 
in 15-30 gelatin capsules; 
consumed water ad libitum; 0.138 
g·kg-1 NaCl placebo; participants 
also consumed 3 x 150 ml water 
and 3 x 150 ml carbohydrate 
solution during testing 
 
90 and 20 minutes pre 
intermittent sprint 
testing; each dose 
consumed over 30 
minutes (e.g. first dose 
consumed 110-90 min 
pre-exercise) 
Intermittent sprint test 
comprised of 2-minute blocks: 
4-second maximal sprints; 100-
second active recovery; 20-
second passive rest; also 
contained 2 repeated sprint 
bouts: 5 x 2- seconds with 18-
second rest periods 
 
Total work output and 
peak power tended to 
increase during 2nd half of 
the sprint test, but results 
not significant  
Edge et al. 
(2006) 
 
 
 
 
 
 
 
Matsuura 
et al. 
(2007) 
16 moderately 
trained females; 
age = 19 ± 1 
years 
 
 
 
 
 
8 recreationally-
trained males; 
age = 20.8 ± 2.1 
years 
2 x 0.2 g·kg-1 NaHCO3 consumed 
during training; 0.1 g·kg-1 NaCl 
placebo 
 
 
 
 
 
 
0.3 g·kg-1 NaHCO3 wrapped in 
wafers capsules; divided into 6 
doses consumed every 10 minutes 
with 350 ml of water; 0.3 g·kg-1 
CaCO3 placebo 
90 and 30 minutes before 
each interval training 
session 
 
 
 
 
 
 
Exercise testing began 
approximately 120 
minutes after first dose 
and 60 minutes after last 
dose 
Interval training: 3x/week for 8 
weeks; 6-12 sprint intervals of 
2 minutes ranging from 91-
110% VO2peak; 1-minute rest 
periods between sprints; Time 
to fatigue test: 4-minute 
unloaded cycling followed by 
cycling to exhaustion  
 
10 x 10-second maximal 
cycling sprints; 30-second 
passive recovery periods 
between 8  sprints; 360-second 
passive recovery period 
between 2 sprints 
Alkalosis training resulted 
in greater improvements 
in lactate threshold and 
short-term endurance 
performance 
 
 
 
 
No effect on performance 
or surface EMG activity; 
6 of 8 participants did 
increase mean power 
output during 9th sprint, 
but results not significant 
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Table 1 (continued). 
 
Author Participants Supplementation Dosage Timing Exercise Protocol Performance Results 
Artioli et 
al. (2007) 
23 experienced judo 
competitors; Protocol 
1—9 participants; age = 
21.5 ± 3 years; Protocol 
2—14 participants; age = 
19.3 ± 2.4 years 
0.3 g·kg-1 NaHCO3 in 
gelatin capsules; water 
consumed ad libitum; 0.3 
g·kg-1 CaCO3 placebo 
120 minutes 
prior to exercise 
testing 
Protocol 1—Special Judo Fitness 
Test: 3 x 3 tests (test = 15-second, 
30-second, and 30-second activity 
periods with 10-second rest between 
periods); 5-minute rest periods 
between tests; Protocol 2—Wingate 
for upper limbs: 4 x 30-second 
maximal arm cycling bouts; 3-
minute rest periods between bouts 
 
Protocol 1—Increase in total 
number of throws (significant in 
tests 2 and 3); Protocol 2—
Increase in relative mean power 
(significant in bouts 3 and 4) and 
relative peak power (significant 
in bout 4)  
Materko 
et al. 
(2008) 
 
Zajac et 
al. (2009) 
11 strength-trained 
males; age = 23 ± 2.7 
years 
 
8 competitive youth male 
swimmers; age = 15 ± 
0.4 years 
0.3 g·kg-1 NaHCO3 
dissolved in water; 0.045 
g·kg-1 NaCl placebo 
 
0.3 g·kg-1 NaHCO3 
dissolved in 500 ml 
solution; consumed over 
15- minute period; 
equimolar NaCl placebo 
120 minutes 
prior to exercise 
testing 
 
90 minutes 
prior to exercise 
test 
10-RM bench press and pull press 
tests 
 
 
4 x 50 meter maximal front crawl 
swims; 1-minute passive rest period 
between swims 
No performance enhancement 
 
 
 
Increased completion time of 
swimming test; swim 1 was 
significantly faster; swims 3 and 
4 were faster, but results not 
significant 
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Table 1 (continued). 
 
Author Participants Supplementation Dosage Timing Exercise Protocol Performance Results 
Siegler and 
Hirscher 
(2010) 
10 trained boxers; 
age = 22 ± 3 years 
0.3 g·kg-1 NaHCO3 dissolved 
in 500 ml low-calorie solution; 
consumed over 15-minute 
period; 0.045 g·kg-1 NaCl 
placebo 
 
Approximately 65-
70 minutes prior to 
exercise testing 
4 x 3-minute boxing rounds; 1-minute 
seated rest period between rounds 
Increased punch 
efficacy 
Tan et al. 
(2010) 
 
 
 
 
 
 
 
 
 
Price and 
Simmons 
(2010) 
12 female elite 
water polo 
players; age = 
23.7 ± 3 years 
 
 
 
 
 
 
 
8 male 
intermittent-sport 
athletes; age = 
20.3 ± 1.0 years 
0.3 g·kg-1 NaHCO3 consumed 
with 600 ml of water over 10-
minute period; corn flour 
placebo 
 
(120 minutes prior to 
exercise—pre-exercise meal 
containing 1.5 g·kg-1 
carbohydrate and 600 ml of 
Gatorade) 
 
0.3 g·kg-1 NaHCO3 dissolved 
in 500 ml low-calorie solution; 
consumed over 5-minute 
period; 0.045 g·kg-1 NaCl 
placebo 
90 minutes prior to 
exercise testing 
 
 
 
 
 
 
 
 
 
60 minutes prior to 
exercise testing 
8 x 5-minute exercise blocks simulating 
water polo match; 2-, 3-, and 5-minute 
rest periods between blocks 
 
 
 
 
 
 
 
 
20 x 24-second runs at 100% VO2max      (4 
exercise bouts x 5 runs per bout); 36-
second rest periods between runs 1-4 in 
each bout; 60-second rest period between 
bouts; Performance test—4th bout, run at 
120% VO2max to exhaustion 
No effect on water 
polo match 
performance 
 
 
 
 
 
 
 
 
No improvement in 
performance time or 
distance covered 
during the 
performance test 
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Table 1 (continued). 
 
Author Participants Supplementation Dosage Timing Exercise Protocol Performance Results 
Cameron et 
al. (2010) 
 
 
 
 
 
 
Wu et al. 
(2010) 
 
 
 
 
 
Siegler and 
Gleadall-
Siddall 
(2010)  
 
 
Wahl et al. 
(2010) 
25 elite male 
rugby players; age 
= 21.6 ± 2.6 years 
 
 
 
 
 
9 male collegiate 
tennis players; age 
= 21.8 ± 2.4 years 
 
 
 
 
6 male trained 
swimmers; 8 
female trained 
swimmers; no age 
data presented 
 
11 male athletes; 
age = 26.5 ± 5.6 
years 
0.3 g·kg-1 NaHCO3 dissolved in 
500 ml isotonic sports drink; 
0.045 g·kg-1 NaCl placebo 
 
(consumed 30-minutes after 
standardized snack) 
 
 
(1) 0.3 g·kg-1 NaHCO3  in 250 
ml water; 0.209 g·kg-1 NaCl 
placebo; (2) after 3rd tennis 
game: 0.1 g·kg-1 NaHCO3 in 
100 ml water; 0.07 g·kg-1 NaCl 
placebo 
 
0.3 g·kg-1 NaHCO3 dissolved in 
500 ml low-calorie solution; 
consumed over 15-minute 
period; 0.045 g·kg-1 NaCl placebo 
 
 
0.3 g·kg-1 NaHCO3 suspended 
in 0.2  ml/kg water; CaCO3 
placebo 
65 minutes prior to 
rugby-specific 
warm-up/training; 
~100 minutes prior 
to rugby-specific 
repeated  sprint test 
(RSRST) 
 
(1) 70 minutes 
prior to skill test 1; 
~115 minutes prior 
to skill test 2; (2) 
~35 minutes prior 
to skill test 2 
 
150 minutes prior 
to exercise testing 
 
 
 
 
Consumed over 90-
minute period prior 
to exercise testing 
Rugby-specific exercise protocol 
consisting of 25-minute warm-up 
followed by 9-minute skill drills;  
RSRST: 10 x 40-meter maximal sprints; 
30-second rest periods between sprints 
 
 
 
20-minute tennis skill test (TST1) 
followed by 50-minute simulated tennis 
match comprised of 12 games; tennis 
skill test repeated (TST2) after match 
 
 
 
8 x 25-meter front crawl maximal 
sprints; 5 seconds of recovery between 
sprints 
 
 
 
4 x 30-second maximal cycle sprints; 5 
minutes of recovery between sprints 
No effect on mean 
sprinting performance 
in RSRST 
 
 
 
 
 
Significantly less 
decline in service and 
forehand stroke 
consistency from 
TST1 to TST2 
 
 
2% decrease in total 
swim time 
 
 
 
 
Increase in mean 
power during 3rd and 
4th sprints 
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Other researchers have examined the dose-related effects relative to more prolonged, or 
chronic, NaHCO3 supplementation. Dourodous et al. (2006) investigated the effects of 
five days of supplementation with amounts equaling 0.3 g·kg-1·day-1 or 0.5 g·kg-1·day-1. 
The authors found that both doses elevated pH and HCO3-, but there was no significant 
difference between the two doses. McNaughton et al. (2000) conducted a similar study 
using only 0.5 g·kg-1·day-1, but in this case, the authors examined changes in pH and 
HCO3- after every day of supplementation. While pH and HCO3- were elevated after each 
dose, there was no additive effect, with the values peaking after the first day of 
supplementation. In a more recent study, Siegler et al. (2009) investigated the time-
course effects of various NaHCO3 dosages. After administering doses of 0.1, 0.2, or 0.3 
g·kg-1, the authors found that blood buffering capacity was significantly increased only 
after doses of 0.2 and 0.3 g·kg-1, with no differences between the two dosages. 
 The HIE studies utilized dosages ranging from 0.15 g·kg-1 (McKenzie et al., 1986) 
to 0.5 g·kg-1 (McNaughton et al., 2000). In agreement with Horswill et al. (1988), 
McKenzie et al. (1986) found that a dose of 0.15 g·kg-1 significantly elevated pH and 
HCO3-. In the same study, the authors also administered 0.3 g·kg-1. While the higher 
dosage resulted in higher extracellular pH and HCO3-, there was no statistically 
significant difference between doses. The authors concluded that a dose of 0.15 g·kg-1 
was adequate to enhance blood buffering capacity and performance (McKenzie et al., 
1986). While recent evidence suggests that a dosage as low as 0.1 g·kg-1 can enhance 
blood buffering capacity (Siegler et al., 2009), past research suggests doses this low are 
not beneficial to performance (McNaughton, 1992).  However, McNaughton (1992) 
examined one bout of high-intensity exercise, whereas McKenzie et al. (1986) utilized a 
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repeated-bouts protocol. Research indicates that repeated bouts of high-intensity exercise 
generate a larger pH gradient than continuous exercise due to the accumulation of 
intracellular H+ (Hermansen & Osnes, 1972; Matson & Tran, 1993). This pH gradient, 
potentiated by 0.15 g·kg-1 NaHCO3 administration, may be why McKenzie et al. (1986) 
found significant improvement in performance.  The vast majority (~79%) of HIE 
studies, however, administered doses of 0.3 g·kg-1.  All of the studies utilizing this 
amount found significant increases in blood buffering capacity, when measured. For 
example, Siegler and Hirscher (2010) found that a dose of 0.3 g·kg-1 elevated resting 
blood pH from 7.37 to 7.43 units, HCO3- from 23.9 to 29.0 milliequivalents per liter 
(mEq·l-1), and base excess (BE) from -0.03 to 5.7 mEq·l-1. BE is another measure of 
blood buffering capacity, with negative values indicating a more acidic environment and 
positive values indicating a more alkaline environment (Andersen & Engel, 1960). 
Similar to Siegler and Hirscher (2010), Webster et al. (1993) found that NaHCO3 
administration increased pH from 7.39 to 7.46 units, HCO3- concentration from 22.9 to 
28.2 mEq·l-1, and BE from -1.3 to 4.4 mEq·l-1. As previously noted, statistically 
significant increases in pH are typically in the range 0.05 to 0.1 units, while significant 
increases in HCO3- concentration are in the range of 5 to 6 mEq·l-1 (Webster, 2002). 
While most of the HIE studies only analyzed extracellular (i.e., blood) variables, 
Bishop et al. (2004) examined intramuscular pH (pHi) as well. The researchers found that 
resting pHi was not affected by an alkalizing agent (pHi placebo = 7.12, pHi NaHCO3 = 
7.11). These results are in agreement with a recent non-HIE study. Forbes et al. (2005) 
found that administering a dose of 0.3 g·kg-1 did not affect resting pHi (pHi placebo = 
7.06, pHi NaHCO3 = 7.09). The results of these studies are consistent with the idea that 
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the sarcolemma is not readily permeated by extracellular HCO3- (Coombes & 
McNaughton, 1993). Therefore, there appears to be no buffering effects of an elevated 
HCO3- reserve at rest when the pH gradient is minimal (Bishop et al., 2004). The 
ergogenic potential of NaHCO3 supplementation appears to be greatest when the pH 
gradient is maximized by an elevated HCO3- reserve and excessive intracellular H+ 
production. This concept is exemplified by an interesting study conducted by Maughan et 
al. (1986). In addition to administering NaHCO3 to induce alkalosis, the authors also 
administered ammonium chloride (NH4Cl) to induce a state of acidosis.  NH4Cl 
administration resulted in significant decreases in pH (from 7.37 to 7.26), HCO3- 
concentration (from 24.4 to 16.8 mEq·l-1), and BE (from 0.2 to -8.6 mEq·l-1). Conversely, 
NaHCO3 supplementation resulted in significant increases in pH (from 7.39 to 7.42), 
HCO3- (from 24.1 to 27.0 mEq·l-1), and BE (0.0 to 3.5 mEq·l-1). The authors found that 
alkalosis enhanced isometric endurance capacity at low muscular tension, while acidosis 
inhibited endurance capacity. This suggests that the reduction in extracellular pH reduced 
the efflux of lactate and H+ from the cell, ultimately accelerating the exercise-induced 
decrease in pHi and onset of fatigue (Maughan et al., 1986). It appears that all of the HIE 
NaHCO3 dosages examined in this review can enhance blood buffering capacity by 
elevating pH and HCO3- reserve. With this being the case, whether there is a strong 
enough pH gradient to facilitate H+ efflux seems dependent upon the exercise protocol. 
 Of the 23 studies that utilized 0.3 g·kg-1 NaHCO3, 12 found significant ergogenic 
effects of supplementation (see Table 1 for Performance Results). An additional six 
studies indicated potential for performance enhancement, but the results of those studies 
were not statistically significant (Gaitanos et al., 1991; Kozak-Collins et al., 1994; 
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Matsuura et al., 2007; Parry-Billings & MacLaren, 1986; Portington et al., 1998; Webster 
et al., 1993). Only five of the 0.3 g·kg-1 studies indicated no trend toward performance 
enhancement (Aschenbach et al., 2000; Cameron, McLay-Cooke, Brown, Gray, & 
Fairbairn, 2010; Materko et al., 2008; Price & Simmons, 2010; Tan et al., 2010). Some of 
the methodology of these studies, which will be discussed below, may have accounted for 
the lack of ergogenic evidence. Other NaHCO3 doses of 0.2 g·kg-1 (Costill et al., 1984), 
0.24 g·kg-1 (Gao et al., 1988), 0.4 g·kg-1 (Edge et al., 2006; Verbitsky et al., 1997), and 
0.5 g·kg-1 (McNaughton et al., 2000) all demonstrated ergogenic effects, with such 
performance enhancements as a 42% increase in cycling time to fatigue (Costill et al., 
1984) and significantly faster swimming bouts (Gao et al., 1988). 
 Timing of administration. Another confounding variable that often makes the 
results of NaHCO3 studies difficult to interpret is timing of administration. Even within 
the specific realm of HIE studies, there is wide variability in the timing of administering 
the NaHCO3 dose. Historically, the time period for completely ingesting the supplement 
has ranged from an “all at once” dose, to an ingestion period spanning three hours 
(Matson & Tran, 1993). The time between completion of ingestion and initiation of 
exercise testing has been equally as variable, with acute supplementation being 
completed anywhere from immediately before exercise to three hours before exercise 
(Matson & Tran, 1993). In fact, chronic dosing schemes may be completed the day 
before exercise testing (McNaughton et al., 2000). To elucidate the appropriate time-
course for NaHCO3 administration, Renfree (2007) examined extracellular H+ 
concentrations at various times following administration of 0.3 g·kg-1, divided into three 
equal doses consumed every 15 min. The author found that the greatest decrease in H+ 
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concentration (and consequent increase in pH) occurred between 60 and 90 min post 
ingestion. Also of interesting note is the fact that, by 150 min, there was no significant 
difference between the NaHCO3 or placebo groups in terms of extracellular H+ 
concentration, although the pH of the NaHCO3 group remained higher until 180 min post 
ingestion (Renfree, 2007). A more recent study by Siegler et al. (2009) is in agreement 
with, and builds upon, the results obtained by Refree (2007). For dosages of 0.2 and 0.3 
g·kg-1, the authors determined that peak blood buffering capacity occurred at 
approximately 45 and 65 min, respectively (Siegler et al., 2009). In the same study, 
Siegler et al. (2009) also compared chronic dosing to acute dosing, and determined that 
acute dosing was superior to chronic dosing, in terms of the timing associated with 
establishing the necessary pH gradient to enhance performance.  
  The selected HIE studies have wide variability in the timing of administration, 
with completion of acute ingestion ranging from 60 to 150 min prior to exercise testing. 
Only six of the studies (Aschenbach et al., 2000; McKenzie et al., 1986; Price et al., 
2003; Price & Simmons, 2010; Siegler & Hirscher, 2010; Verbitsky et al., 1997) initiated 
exercise testing during the time frame in which Siegler et al. (2009) suggested peak blood 
buffering occurred. HIE or prolonged interval exercise results in a gradual, yet 
substantial, H+ accumulation over the course of the intervals (Hermansen & Osnes, 1972; 
Matson & Tran, 1993). This is likely the reason why the ergogenic potential for NaHCO3 
supplementation demonstrated by HIE studies often occurs during the later bouts of 
exercise (Artioli et al., 2007; Bishop et al., 2004; Maughan et al., 1986; McKenzie et al., 
1986; Price et al., 2003; Wahl, Zinner, Achtzehn, Bloch, & Mester, 2010; Zajac et al., 
2009). This means that many of the HIE studies have possibly utilized protocols that 
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produced the greatest H+ accumulation during the time frame in which blood buffering 
potential was already tapering.  For example, Bishop and Claudius (2005) examined the 
effects of NaHCO3 administration on a prolonged HIE task comprised of two 36-min 
sessions. While the authors did not find any significant performance effects, they did note 
a trend toward enhanced performance during the second session. The supplementation 
protocol involved two doses of 0.2 g·kg-1, with the first dose being consumed 90 min 
prior to exercise and the second dose being consumed 20 min prior to exercise testing 
(Bishop & Claudius, 2005). Based on the work of Siegler et al. (2009), this suggests that 
peak pH and HCO3- levels occurred at the beginning of the second session, which began 
approximately one hour after completion of ingestion. Given that the second session 
lasted 36 min (Bishop & Claudius, 2005), it is probable that blood buffering capacity was 
tapering, as shown by Siegler et al. (2009), during the time of excessive H+ production. 
This demonstrates the importance of appropriate timing of administration of NaHCO3. If 
too much time lapses between completion of ingestion and exercise, ergogenic potential 
may be reduced. This is also possibly the case in the study conducted by Parry-Billings 
and MacLaren (1986). The researchers administered NaHCO3 approximately 150 min 
prior to exercise testing. Subsequently, the researchers found that, although a trend was 
present for enhanced performance, the results were not statistically significant (Parry-
Billings & MacLaren, 1986). This seems to be in line with the study by Renfree (2007) 
which found there were no significant pH differences between NaHCO3 or placebo 
supplementation at 150 min post-ingestion. 
 Placebo. Along with the confounding variables of dosage and timing, the placebo 
utilized should be carefully considered. The three placebos administered in HIE studies 
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were NaCl, calcium carbonate (CaCO3), and flour (see Table 1 for Supplementation). 
Although the majority (~62%) of the studies used NaCl as a placebo, previous research 
suggests that NaCl may not be physiologically inert (Bishop et al., 2004). Along these 
lines, Lavender and Bird (1989) found that NaCl administration alone enhanced cycling 
sprint performance. Researchers have postulated that the increase in extracellular Na+ 
concentration accompanying NaCl administration may confer ergogenic effects through 
increased plasma volume and tissue perfusion (Mitchell et al., 1990), elevated H+ efflux 
due to upregulation of the Na+/ H+ exchanger (Bishop et al., 2004), or elevated 
extracellular HCO3- concentration due to disturbances in strong ion equilibrium 
(Heigenhauser & Jones, 1991). Aschenbach et al. (2000) conducted a study to examine 
the effects on performance of equimolar amounts of Na+ from either NaHCO3 or NaCl. 
The researchers found that NaCl had no effect on pH or performance, relative to a low-
calorie beverage placebo (Aschenbach et al., 2000). To avoid the potential physiological 
effects of NaCl, researchers have used a CaCO3 placebo. In general, NaHCO3 studies that 
have used CaCO3 as a placebo have tended to find significant ergogenic effects, more so 
than those studies using large NaCl dose placebos (Linderman & Fahey, 1991). However, 
only five of the HIE studies utilized CaCO3 placebos (Artioli et al., 2007; Coombes & 
McNaughton, 1993; Matsuura et al., 2007; Maughan et al., 1986; Wahl et al., 2010). Of 
these studies, only one did not find a significant ergogenic effect for NaHCO3, although 
there was a trend for enhanced performance (Matsuura et al., 2007). There was large 
variability in NaCl doses for those studies using NaCl as the placebo. Dosages ranged 
from as little as one gram of NaCl (Costill et al., 1984), to as large 0.21 g·kg-1 
(Aschenbach et al., 2000), which would equate to approximately 15 grams of NaCl for 
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the average participant. Based on supplementation protocols alone, there is no apparent 
trend among the HIE studies indicating a superior dosage of NaCl, in terms of 
establishing ergogenic effects for NaHCO3 administration. Although past research 
suggests that lower NaCl doses, when compared to higher doses, are more highly 
correlated with NaHCO3 ergogenic effects (Linderman & Fahey, 1991), this trend is not 
seen when examining the selected HIE studies. NaCl placebo doses as low as 1.5 grams 
(Gaitanos et al., 1991) and 0.045 g·kg-1 (Materko et al., 2008) were not associated with 
ergogenic effects of NaHCO3, while NaCl doses as high as 8 grams (Lavender & Bird, 
1989) and 0.207 g·kg-1 (Bishop et al., 2004) were utilized in studies that demonstrated 
alkalosis-induced performance enhancements.  None of the HIE NaHCO3 studies using a 
flour placebo demonstrated an ergogenic effect (Portington et al., 1998; Tan et al., 2010; 
Webster et al., 1993), although it is unlikely that the results of these studies were strongly 
affected by placebo.  
Side effects and administration details. The typical NaHCO3 dose of 0.3 g·kg-1 
equates to 21 grams of NaHCO3 for the 70 kg athlete. Consuming dosages this large can 
increase the osmolality of the gastrointestinal (GI) tract (Requena et al., 2005). This 
increase in solute concentration in the gut can draw water from the plasma back into the 
GI tract to create an isotonic solution (Linderman & Gosselink, 1994; Webster, 2002). 
This influx of water can lead to symptoms such as GI discomfort, diarrhea, cramps, and 
bloating (Linderman & Gosselink, 1994). Cameron et al. (2010) detailed the GI distress 
symptoms experienced by 25 elite rugby players after consumption of 0.3 g·kg-1 
NaHCO3. Commonly reported symptoms included nausea, flatulence, stomach cramping, 
belching, stomachache, bowel urgency, diarrhea, vomiting, and stomach bloating. 
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Interestingly, even though the participants experienced significantly greater GI distress 
with NaHCO3 when compared to placebo, the participants reported lower ratings of 
perceived exertion (RPE) during the NaHCO3 condition (Cameron et al., 2010). To 
prevent GI distress, researchers have tried various alterations in the supplementation 
protocol, such as administering doses with large volumes of fluid (e.g., 500-2000 ml) and 
dividing dosages into smaller amounts consumed in increments (Burke & Pyne, 2007). 
Interestingly, Heigenhauser and Jones (1991) have reported that large volumes of water, 
up to 1.5 l, not only decrease the potential for GI disturbances, but also enhance alkalosis. 
Very few of the HIE studies commented on side effects of supplementation, with only 
five studies reporting any negative effects (Cameron et al., 2010; Kozak-Collins et al., 
1994; Price & Simmons, 2010; Siegler & Hirscher, 2010; Webster et al., 1993). Reported 
fluid consumption ranged from 300 ml (Gao et al., 1988) to 2.1 l (Matsuura et al., 2007), 
although not all of the studies detailed fluid intake (see Table 1 for Supplementation). 
The most commonly recorded amounts of fluid consumption were 400 ml (Coombes & 
McNaughton, 1993; Costill et al., 1984; Lavender & Bird, 1989) and 500 ml (Bishop et 
al., 2004; Cameron et al., 2010; Gaitanos et al., 1991; Price & Simmons, 2010; Siegler & 
Gleadall-Siddall, 2010; Siegler & Hirscher, 2010; Zajac et al., 2009), which is 
substantially less than the 1.5 l recommended by Heigenhauser and Jones (1991). Several 
researchers allowed fluid to be consumed ad libitum (Artioli et al., 2007; Bishop & 
Claudius, 2005; Kozak-Collins et al., 1994; Maughan et al., 1986; Portington et al., 1998; 
Webster et al., 1993; Wu et al., 2010), with only Portington et al. (1998) and Wu et al. 
(2010) measuring ad libitum fluid intake (~1.4 and 1.1 l, respectively).  
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With fluid intake exerting important effects on alkalinizing capacity and GI 
distress prevention, it appears that fluid consumption should be more tightly regulated. 
The same could be said of incremental NaHCO3 dosage administration. Most HIE 
researchers attempted to break the dosages into smaller amounts by either allowing a 
certain time frame for consumption or by employing a stacking method of consumption. 
The most commonly reported intervals for supplement consumption were 5- to 15-min 
periods (see Table 1), while incremental ingestion periods as high as 50 min (Matsuura et 
al., 2007) and 150 min (Maughan et al., 1986) were also utilized. Several studies 
employed what Siegler et al. (2009) refer to as a “stacking” protocol. This type of 
protocol is exemplified in the study by Aschenbach et al. (2000). The researchers 
administered supplementation in two equal doses at 90 and 60 min prior to exercise. This 
method was effective in enhancing blood buffering capacity and preventing GI distress 
(Aschenbach et al., 2000). Since all of the HIE supplementation methods resulted in 
enhanced blood buffering capacity, it seems logical that the method selected should focus 
on appropriate timing, while attempting to prevent GI disturbances. In attempt to bypass 
the gut, and therefore eliminate the risk of GI disturbances, investigators have infused 
NaHCO3 intravenously (Granier et al., 1996; Wijnen, Verstappen, & Kuipers, 1984). 
Although NaHCO3 infusion has improved HIE performance (Wijnen et al., 1984), this 
method is impractical in most field or competitive settings. The more practical practice of 
oral administration has been implemented in a variety of ways, such as dissolving 
NaHCO3 in water (Materko et al., 2008), a flavored low-calorie beverage (Aschenbach et 
al., 2000), or soup (Parry-Billings & MacLaren, 1986), and by administration through 
gelatin capsules (Bishop et al., 2004; Webster et al., 1993). With regard to enhancing the 
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blood buffering capacity, there appears to be no difference in NaHCO3 administration 
through fluids or capsules (Matson & Tran, 1993). 
NaHCO3 supplementation summary. NaHCO3, more commonly known as baking 
soda, is a sodium salt that has commonly been administered to induce alkalosis. 
Historically, the typical administered dosage has been 0.3 g·kg-1.  This holds true for HIE 
research, with the majority of the selected studies utilizing this dose, although doses 
ranging from as little as 0.15 g·kg-1 to as much as 0.5 g·kg-1 have been reported. All HIE 
NaHCO3 dosages elevated blood buffering capacity, as evidenced by an increase in 
extracellular pH, HCO3- reserve, and BE. In addition to supplementation amount, three 
other important factors to consider when dosing with NaHCO3 are timing of 
administration, placebo, and side effects. Evidence suggests that peak plasma levels of 
pH and HCO3- occur approximately 60 min after ingestion. If this is the case, then many 
of the HIE studies failed to capitalize on peak buffering capacity since most of the studies 
initiated exercise testing more than 60 min after ingestion. NaCl was the most commonly 
used placebo for the HIE studies, even though some research indicates that this placebo is 
not physiologically inert.  CaCO3 is an alternative placebo that does not exert any effect 
on buffer capacity or performance and was used in a small number of the HIE studies. 
Lastly, GI distress can result from NaHCO3 supplementation due to the concentrated load 
imposed on the gut. To contend with this side effect, researchers have administered 
NaHCO3 in incremental doses with large volumes of water. Although the methodology 
varied, this was the common practice in the selected HIE studies and was effective in 
minimizing or preventing GI disturbances.       
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HIE Protocols and Performance Results 
 The studies selected for more extensive review were chosen because they utilized 
exercise protocols that involved repeated bouts of high-intensity exercise interspersed 
with brief rest periods. The major focus of this document is the potential ergogenic 
benefit of NaHCO3 supplementation for HRE. Since relatively few studies have 
examined the effect of induced alkalosis on resistance exercise, the details of various 
types of HIE studies are included here to provide a more complete picture of the effects 
of NaHCO3 administration on intense interval exercise. The HIE studies not only 
employed variable supplementation methodology, but they also utilized a variety of 
exercise protocols (see Table 1 for Exercise Protocol). In order to compare the different 
protocols and performance results, the HIE studies have been placed in the following 
groups based on exercise modality: cycling, running, swimming, sport-specific, and 
resistance exercise. 
 Cycling. The most commonly used exercise mode to assess HIE was cycling, with 
12 studies examining the effects of induced-alkalosis on cycle ergometry performance 
(see Table 1). The cycling protocols can be further subdivided on the basis of brief (6-30 
s), intermediate (60 s), and more prolonged (120-180 s) intervals. Bishop et al. (2004) 
utilized the shortest cycling intervals to examine the effects of induced alkalosis on repeat 
sprint ability. Using five, 6-s maximal sprint intervals interspersed with 24 s of recovery, 
the authors found that NaHCO3 administration increased total work and peak power, 
primarily during the later sprints (Bishop et al., 2004). Similar to these findings are those 
presented by Lavender and Bird (1989). These researchers utilized a slightly longer 
protocol, including ten, 10-s maximal sprints with 50-s rest periods between sprints. 
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Lavender and Bird (1989) found that induced-alkalosis increased both peak and average 
power, demonstrating the ergogenic potential of NaHCO3. Matsuura et al. (2007) 
conducted a similar study to Lavender and Bird (1989), with the only difference 
occurring in the rest interval times. The authors used rest periods of 30-s between most of 
the sprint intervals, although two, 6-min rest periods were utilized during the protocol to 
examine the effects of PCr repletion on subsequent performance. In contrast to the 
previous studies (Bishop et al., 2004; Lavender & Bird, 1989), Matsuura et al. (2007) did 
not find significant increases in performance. However, the authors did notice a trend of 
increased power output during the ninth sprint of the NaHCO3 group. Parry-Billings and 
MacLaren (1986) conducted a similar study to Matsuura et al. (2007) in that the authors 
used 6-min rest periods and did not find an ergogenic effect. Parry-Billings and 
MacLaren (1986), however, only used three, 30-s maximal sprint intervals. Although the 
results were not significant, the authors did note a trend for increased peak and mean 
power, as well (Parry-Billings & MacLaren, 1986). Whereas Parry-Billings and 
MacLaren (1986) did not find significant results, McNaughton et al. (2000) did 
demonstrate the ergogenic efficacy of NaHCO3 using a very similar protocol. The 
researchers found that induced-alkalosis increased total work and peak power output in a 
protocol that utilized three, 30-s maximal sprints (McNaughton et al., 2000). Along these 
same lines, Wahl et al. (2010) also demonstrated ergogenic effects utilizing a protocol 
involving four, 30-s maximal cycling sprints, interspersed with 5-min rest periods. The 
investigators found that NaHCO3 administration significantly improved mean power 
output during the third and fourth sprints (Wahl et al., 2010).   
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Costill et al. (1984) conducted some of the pioneering research on HIE, 
examining the effects of induced-alkalosis on intermediate-length sprint intervals. This 
exercise protocol involved four, 60-s cycling bouts interspersed with 60-s rest periods. A 
fifth cycling bout to fatigue was used as a performance test. The researchers found an 
impressive 42% increase in time fatigue (Costill et al., 1984), with these results 
stimulating interest in the ergogenic potential of NaHCO3 for interval protocols. 
McKenzie et al. (1986) and Kozak-Collins et al. (1994) conducted very similar studies to 
that of Costill et al. (1984), but with equivocal results. The findings of McKenzie et al. 
(1986) are in agreement with those of Costill et al. (1984). The researchers found that two 
levels of NaHCO3 administration improved a performance test proceeding five, 60-s 
cycling bouts interspersed with 60-s rest periods (McKenzie et al., 1986). In contrast, 
Kozak-Collins et al. (1994) did not find significant improvements in the number of 60-s 
cycling intervals that could be completed at an intensity corresponding to 95% VO2max, 
with 60-s rest periods between intervals. However, the authors did note that a trend 
toward performance enhancement was apparent (Kozak-Collins et al., 1994). 
The last three cycling protocols to be discussed utilized more prolonged sprint 
intervals, lasting at least two minutes. Price et al. (2003) used a prolonged intermittent 
protocol comprised of three, 10-min blocks at various intensities, ranging from 40% 
VO2max to “all out” sprinting, with 14 s of active recovery between blocks. The authors 
found ergogenic potential for NaHCO3, demonstrating that power output at the end of the 
protocol was maintained at a similar level to that seen at the beginning (Price et al., 
2003). Similar, albeit insignificant, results were obtained by Bishop and Claudius (2005) 
using a more prolonged protocol involving two, 36-min sessions designed to simulate the 
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energy demands of field hockey. Although the protocol, which involved 2-min exercise 
blocks, did not elicit significant performance enhancement for the NaHCO3 group, a 
trend of improved performance was seen during the second 36-min session (Bishop & 
Claudius, 2005). Lastly, Edge et al. (2006) conducted an interesting study to examine the 
effects of induced-alkalosis on interval training. This protocol involved training three 
times per week, for eight weeks, after NaHCO3 ingestion. Each training session involved 
6-12 sprint intervals lasting two minutes each, with 60-s rest periods between sprints. The 
authors found that training after induced-alkalosis ultimately resulted in an improvement 
in lactate threshold and short-term endurance performance (Edge et al., 2006). 
Running and swimming. Whereas a relatively large number of HIE studies utilized 
cycling protocols, the modalities of running (Gaitanos et al., 1991; Price & Simmons, 
2010) and swimming (Gao et al., 1988; Zajac et al., 2009) were much less common. 
Gaitanos et al. (1991) examined the effects of NaHCO3 administration on short duration 
maximal running. The results of this study, which involved 10, 6-s sprints on a non-
motorized treadmill, indicated that induced-alkalosis was not beneficial to this type of 
performance. However, the authors did indicate that a trend for higher power outputs and 
total work completed was seen in the alkaline condition (Gaitanos et al., 1991). Price and 
Simmons (2010) conducted another HIE running study to examine the effects of NaHCO3 
on a performance test that was preceded by repeated sprints. The repeated sprints 
consisted of 20, 24-s runs at 100% VO2max, with variable rest periods between sprints. 
Following the sprints, the researchers conducted a performance test that required running 
until exhaustion at an intensity of 120% VO2max. There were no significant improvements 
in performance test time to exhaustion or distance covered, suggesting that NaHCO3 
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supplementation was not beneficial for this type of exercise task (Price & Simmons, 
2010). Whereas these HIE running studies failed to demonstrate the ergogenic potential 
of NaHCO3, previous studies have utilized induced-alkalosis to enhance running 
performance. For example, Wilkes et al. (1983) and Goldfinch et al. (1988) utilized 
racing protocols that, while not intermittent, still heavily taxed the glycolytic energy 
system. Induced-alkalosis resulted in faster 400-meter (m) (Wilkes et al., 1983) and 800-
m (Goldfinch, McNaughton, & Davies, 1988) racing times. Taken together, this suggests 
that the HIE running studies may not have used long enough running durations to create 
significant acidosis.    
Although previous studies investigating the effects of induced-alkalosis on 
swimming can technically fall under the genre of HIE (Mero, Keskinen, Malvela, & 
Sallinen, 2004; Pierce, Eastman, Hammer, & Lynn, 1992), only three swimming studies 
(Gao et al., 1988; Siegler & Gleadall-Siddall, 2010; Zajac et al., 2009) were located that 
involved protocols consistent with the other selected HIE methodology (i.e., short rest 
periods). Gao et al. (1988) examined the effects of NaHCO3 on five bouts of near-
maximal, 100-yard front crawl swimming, interspersed with 2-min rest periods. The 
authors found an ergogenic effect for supplementation, with the times to complete bouts 
four and five being significantly faster in the NaHCO3 trial (Gao et al., 1988). Zajac et al. 
(2009) utilized a similar, albeit shorter, protocol to that of Gao et al. (1988) and obtained 
similar results. In order to examine the effects of NaHCO3 administration on the 
swimming performance of youth athletes, the researchers used a protocol that required 
four, 50-m (~55 yards) maximal, front crawl swims, with 60-s rest intervals between 
bouts. Zajac et al. (2009) found that the time to complete the entire protocol was 
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significantly faster in NaHCO3 trial. Similar to the results of Gao et al. (1988), there was 
a trend for the third and fourth bouts to be faster, although only the first swimming bout 
was significantly faster (Zajac et al., 2009). In a more recent HIE swimming study, 
Siegler and Gleadall-Siddall (2010) established the ergogenic efficacy for induced-
alkalosis on a protocol utilizing shorter sprint durations and rest periods than the previous 
two studies. Participants completed eight maximal 25-m front crawls, with 5-s rest 
periods interspersed between sprints. The authors found that NaHCO3 supplementation 
resulted in a significant 2% decrease in total time required to complete all sprints (Siegler 
& Gleadall-Siddall, 2010).   
Sport-specific. Some of the more interesting methodology is that seen in those 
HIE studies that can be classified as “sport-specific.” The elaborate cycling protocol of 
Bishop and Claudius (2005), as detailed above, could have been placed into this 
grouping, since the exercise protocol was designed to mimic the energy requirements of 
field hockey. Recently, Tan et al. (2010) investigated the effects of NaHCO3 on a 
simulated water polo match. The researchers utilized a protocol comprised of eight, 5-
min blocks of exercise similar to that experienced during a polo match, with rest periods 
ranging from two to five minutes between blocks. The results of this study indicated that 
that NaHCO3 was not an effective ergogenic aid for this type of exercise (Tan et al., 
2010). Similar to the results obtained by Tan et al. (2010), Cameron et al. (2010) found 
that NaHCO3 supplementation was not beneficial to simulated rugby performance. The 
methodology of this study required elite rugby players to complete a rugby-specific 
repeated-sprint test following 34 min of rugby-specific warm-up and drills (Cameron et 
al., 2010). In another recent sport-specific study, Siegler and Hirscher (2010) examined 
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the effects of induced-alkalosis on boxing performance. A performance enhancing effect 
was demonstrated as the boxers achieved greater punch efficacy over the course of the 
protocol, which involved four, 3-min simulated boxing rounds (Siegler & Hirscher, 
2010). Wu et al. (2010) also established ergogenic efficacy for NaHCO3 administration 
before sport-specific testing. To assess the effect of NaHCO3 on tennis performance, the 
researchers administered a tennis-specific skill test before and after a simulated tennis 
game. Induced-alkalosis prevented a decline in tennis skill performance (Wu et al., 2010). 
An ergogenic effect for NaHCO3 administration before sport-specific exercise testing was 
demonstrated by Artioli et al. (2007), as well. These investigators examined the effects of 
induced-alkalosis on Judo performance, utilizing a complex fitness test and arm 
ergometry. The Judo fitness test involved three bouts of a simulated sparring exercise in 
which the total number of successful throws were assessed. In the same study, the 
researchers investigated arm ergometry performance with four, 30-s maximal cycling 
bouts, interspersed with 3-min rest periods. Induced-alkalosis enhanced performance in 
both of these protocols, resulting in more total throws during the fitness test and greater 
relative mean and peak power during the arm ergometry (Artioli et al., 2007). Arm 
ergometry was also the exercise mode chosen by Aschenbach et al. (2000) to assess the 
effects of NaHCO3 administration on the performance of collegiate wrestlers. In contrast 
to Artioli et al. (2007), Aschenbach et al. (2000) did not demonstrate the ergogenic 
efficacy for induced-alkalosis during an exercise protocol that utilized eight, 15-s 
maximal cycling bouts, interspersed with 20 s of active recovery. 
Resistance exercise. The last HIE group, which is central to this review, includes 
those studies examining the effects of NaHCO3 administration on resistance exercise 
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performance. In an early study, Maughan et al. (1986) examined the effects of induced-
alkalosis on sustained contractions of the knee extensors. The protocol required 
contractions until failure at varying percentages (20, 50, and 80%) of the maximal 
voluntary contraction (MVC) capability, with 5-min rest periods between efforts. The 
investigators found that alkalosis did enhance performance, but only during the 20% 
MVC trial (Maughan et al., 1986). Coombes and McNaughton (1993) also demonstrated 
the ergogenic potential of induced-alkalosis on resistance exercise. These researchers 
assessed muscular endurance and strength of the leg extensors and flexors with two sets 
of isokinetic exercise. The first set assessed 4-repetition strength, while the second set 
examined 60-repetition endurance capacity. Study results demonstrated the efficacy of 
NaHCO3 supplementation, indicating an increase in total work completed and peak 
torque (Coombes & McNaughton, 1993). An interesting study by Verbitsky et al. (1997) 
examined muscle fatigue and recovery using electrical stimulation (e-stim) and supra-
maximal cycling. The resistance aspect of this study involved isometric e-stim actions of 
the knee extensors before and after three minutes of intense isotonic cycling. The authors 
found that induced-alkalosis resulted in greater peak and residual torques following the 
cycling bout, indicating that NaHCO3 administration delayed fatigue and improved 
recovery between exercise sets (Verbitsky et al., 1997).  
Webster et al. (1993) were the first to examine NaHCO3 supplementation on high-
volume resistance exercise. This protocol required four sets of 12 repetitions of the leg 
press exercise at 70% 1-RM, with 90 s of recovery between sets. A fifth set to muscular 
failure with the same load was utilized as a performance test. The researchers found that, 
although the results were not significant, there was a trend toward increased repetitions in 
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the performance test (Webster et al., 1993). Portington et al. (1998) followed up the study 
by Webster et al. (1993) with a very similar, yet more intense, protocol. In this study, five 
sets of maximal leg presses (~12-RM) were utilized, with total repetitions completed 
serving as the performance parameter. Similar to the previous results, Portington et al. 
(1998) found a trend toward increased repetitions, although the results were not 
significant. The most recent study examining the effects of induced-alkalosis on 
resistance exercise does not fall under the HIE genre, per se. Materko et al. (2008) 
assessed the effects of NaHCO3 administration on only one set of muscular strength 
exercise. In contrast to Coombes and McNaughton (1993), the authors found that 
supplementation did not improve strength, as evidenced by no performance increase in 
the bench and pull press exercises at an intensity of 10-RM (Materko et al., 2008). 
Efficacy of supplementation and methodological considerations. Of the selected 
studies contained within this review, 17 found that NaHCO3 administration significantly 
improved performance, while an additional seven indicated that there was a trend toward 
elevated performance (see Table 1). This means that only five of the reviewed studies 
failed to demonstrate any ergogenic potential for NaHCO3 supplementation (Aschenbach 
et al., 2000; Cameron et al., 2010; Materko et al., 2008; Price & Simmons, 2010; Tan et 
al., 2010). However, careful consideration of the methodologies of these studies may 
provide insight into why performance was not enhanced.  
Those HIE studies that did indicate improvements in performance utilized 
methods that not only increased blood buffering capacity through supplementation, but 
also likely created large pH gradients through excessive H+ production. The studies by 
McKenzie et al. (1986) and Siegler and Hirscher (2010) exhibited exemplary methods for 
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performance enhancement. Both studies utilized supplementation protocols that involved 
ingestion of either 0.3 g·kg-1 NaHCO3 or small NaCl placebo approximately 60-70 min 
prior to exercise testing, the time necessary to achieve peak blood buffering capacity 
(Siegler et al., 2009). This enhanced capacity was evidenced by significant increases in 
pH and HCO3- concentration. McKenzie et al. (1986) reported post-ingestion pH and 
HCO3- values of 7.42 units and 27.9 mEq·l-1, respectively. Similarly, Siegler and Hirscher 
(2010) reported post ingestion pH and HCO3- values of 7.43 units and 29.0 mEq·l-1, 
respectively. These values represented significant increases above baseline levels. Both 
of these studies also utilized exercise protocols that rely heavily on fast glycolysis, being 
comprised of intense 1- to 3-min intervals with brief rest periods lasting 60 s. By 
comparison, the methods of the selected studies that did not demonstrate the ergogenic 
benefit of alkalosis were not sufficient in at least one aspect. Given that all of the 
reviewed studies reported enhanced blood buffering capacity (when measured), this 
insufficient methodology was likely due to poor timing of administration, placebo, or 
exercise protocol intensity. For example, the protocol utilized by Tan et al. (2010) 
resulted in a post-exercise pH of 7.32 units and a lactate concentration of only 5.8 mM in 
the placebo trial. The authors reported that previous studies finding ergogenic efficacy for 
NaHCO3 supplementation demonstrated post-exercise pH values of less than 7.2 units 
and lactate concentrations in excess of 10 mM (Tan et al., 2010). This suggests that the 
level of acidosis generated by this type of activity (water polo) is not sufficient enough to 
warrant NaHCO3 administration. Another short-coming of the study may have been 
timing of supplement administration. Ingestion was completed 90 min prior to an 
exercise protocol that involved 40 min of exercise (not including rest periods). Based on 
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the work by Siegler and others (2009), this suggests that the exercise protocol took place 
during a time of tapering extracellular buffer capacity (Tan et al., 2010). Similar to the 
results produced by Tan et al. (2010), Price and Simmons (2010) found induced-alkalosis 
not to be ergogenic, suggesting that the exercise intensity utilized may not have been 
sufficient to elicit excessive H+ production. Inadequate timing and insufficient exercise 
intensity may also have been the confounding factors that prevented Materko et al. (2008) 
from establishing ergogenic effects. In this study, ingestion was completed 120 min prior 
to exercise testing, which involved only one bout of resistance exercise (Materko et al., 
2008). Since PCr depletion is likely the limiting factor in one bout of resistance exercise 
(Lambert & Flynn, 2002), it seems unlikely this type of strength test would benefit from 
NaHCO3 administration. Aschenbach et al. (2000) utilized a protocol with exercise 
interval durations of only 15 s. The authors postulated that PCr depletion may be the 
limiting factor in this type of exercise, even though the large lactate levels produced 
suggest extensive fast glycolysis. However, other studies with intervals of even shorter 
durations (Bishop et al., 2004; Lavender & Bird, 1989) established ergogenic effects, so 
it remains unclear as to why Aschenbach et al. (2000) did not obtain significant results. 
One possibility, though, is the fact that Aschenbach et al. (2000) used trained 
participants. Although trained participants are likely to give more consistent 
performances and therefore incorporate smaller variability (Matson & Tran, 1993), 
training enhances buffering capacity (Edge et al., 2006), possibly reducing the 
effectiveness of supplemental buffering. This may also have been a contributing factor in 
the results found by Cameron et al. (2010). The authors used elite rugby players and 
found no performance enhancement with supplemental NaHCO3. Timing of 
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administration may have been a confounding factor as well, with participants consuming 
the supplement approximately 100 min prior to exercise performance testing (Cameron et 
al., 2010). 
 Methodological considerations of those studies that only demonstrated a trend 
toward enhanced performance may elucidate why the results of those studies only 
approached significance. Two potential complications of the Parry-Billings and 
MacLaren (1986) study were the timing of supplement administration and rest period 
lengths. Exercise testing did not begin until 150 min post ingestion, which is the same 
time frame in which Renfree (2007) found that blood buffering capacity was no longer 
significantly elevated. While this certainly could have influenced the results, the length of 
time between sprints, six minutes, could have had an impact as well. This length of time 
would have been sufficient to allow complete resynthesis of PCr (Cramer, 2008), thereby 
diminishing the energy contributions, and subsequent H+ production, of fast glycolysis. 
Similar to Parry-Billings and MacLaren (1986), Gaitanos et al. (1991) also incorportated 
a 150-min period between ingestion and exercise, likely resulting in testing that occurred 
well after peak blood buffering capacity. Another study with similar methodology to 
Parry-Billings and MacLaren (1986) was that conducted by Matsuura et al. (2007). The 
commonality was in the utilization of 6-min rest periods. Again, allowing this much time 
between sprints likely allowed complete PCr repletion, reducing the contributions of fast 
glycolysis. Along these lines, it is important to note that PCr hydrolysis actually 
consumes H+ (Robergs et al., 2004); so any method that potentiates the contribution of 
PCr to energy production actually reduces, if only briefly, intracellular H+ concentration. 
The 60-s rest periods utilized by Kozak-Collins et al. (1994) are more in accordance with 
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those studies (Costill et al., 1984; Lavender & Bird, 1989; McKenzie et al., 1986; Siegler 
& Hirscher, 2010) employing exercise protocols generating significant acidosis. 
Therefore, other methodological complications, primarily in the supplementation 
protocol, may be responsible for a lack of significant results. Kozak-Collins et al. (1994) 
did not begin exercise testing until 120 min post-ingestion. As previously discussed, this 
may have led to exercise testing after peak blood buffering capacity occurred. In addition, 
the authors administered a large dose of NaCl (0.207 g·kg-1) as a placebo (Kozak-Collins 
et al., 1994). If NaCl is not physiologically inert, as some research suggests (Bishop et 
al., 2004; Lavender & Bird, 1989), then the differences between group performances 
could have been reduced, thereby yielding insignificant results. 
 Only two of the selected studies investigated the effects of induced-alkalosis on 
high-volume resistance exercise (Portington et al., 1998; Webster et al., 1993). In the 
study by Webster et al. (1993), four of the six participants increased number of 
repetitions completed in the performance test, but the results were not significant. This 
led the authors to suggest that NaHCO3 administration during a more intense protocol 
may demonstrate ergogenic effects. To examine this hypothesis, Portington et al. (1998) 
conducted a similar study with a greater intensity. Whereas Webster et al. (1993) utilized 
a resistance load of 70% 1-RM, Portington et al. (1998) used a resistance corresponding 
to approximately 12-RM for each set. This means that all sets were terminated at 
momentary muscular failure, when participants were unable to complete another 
repetition. Similar to the earlier study, seven of the 15 participants increased total number 
of repetitions under induced-alkalosis, but the results were not significant (Portington et 
al., 1998). Even though the protocols of these two studies are considered “high-volume,” 
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this volume of exercise is still substantially less than that seen with typical HRE. For 
example, Portington et al. (1998) reported that, on average, participants completed 
approximately 60 total repetitions throughout the protocol. However, individuals training 
for muscular hypertrophy may complete 15 to 20 exercise sets per muscle group 
(Lambert & Flynn, 2002). Fifteen exercise sets with a 10-RM load equates to 150 total 
repetitions, representing a 150% increase in the volume used by Portington et al. (1998). 
It therefore follows that the ergogenic potential of NaHCO3 is more likely to be 
maximized with an exercise protocol employing the type volume used in typical HRE 
regimens. 
 Exercise protocols and performance summary. The effects of NaHCO3 
administration have been examined on a variety of HIE modalities, among those being 
cycling, running, swimming, sport-specific exercise tests, and resistance exercise. With 
sound methodology, induced-alkalosis has the potential to enhance performance in all of 
these modalities. Twenty-three of the reviewed studies found either significant increases 
in performance or a trend toward enhanced performance following NaHCO3 
supplementation. Those studies not demonstrating significant results may have utilized 
insufficient methodology, such as inadequate exercise intensity or improper timing of 
supplement administration. While no studies evaluated the effects of induced-alkalosis on 
a true HRE protocol, previous research suggests that exercise of this volume and intensity 
may be enhanced through NaHCO3 supplementation.  
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CHAPTER III 
MANUSCRIPT 
The Effects of Sodium Bicarbonate Supplementation on Lower-Body Hypertrophy-Type 
Resistance Exercise 
Introduction 
 Specific muscular adaptations obtained through resistance exercise are dependent 
upon training program design, with programs targeting muscle hypertrophy being 
distinctive from those targeting muscular strength or endurance (Baechle et al., 2008; 
Brooks et al., 2000). The American College of Sports Medicine (ACSM) has identified 
several important program design variables, chief among those being exercise load, rest 
periods, and exercise volume. Manipulation of these variables is associated with the 
specific muscular adaptations, with hypertrophy-type resistance exercise (HRE) regimens 
being characterized by moderate loads, short rest periods, and high total volume (ACSM, 
2009). Typically, HRE regimens consist of 8-12-repetition maximums (RM) per exercise 
set (Fleck & Kraemer, 1988; Linnamo et al., 2005; Spiering et al., 2008), rest periods of 
approximately one minute between sets (Bird et al., 2005; de Salles et al., 2009; Kraemer 
et al., 1987), and multiple sets of each exercise—with greater total exercise volumes 
eliciting greater anabolic hormone concentrations (Gotshalk et al., 1997; Smilios, 
Piliandis, Karamouzis, & Tokmakidis, 2003). 
 The fatigue associated with HRE regimens is likely to be multi-faceted, as this 
type of exercise is both intense and prolonged. During intense exercise, multiple energy 
substrates are depleted with the concurrent accumulation of metabolites, making it 
difficult to determine if energy depletion or end/waste-product accumulation is the 
primary cause of fatigue. For example, during high-intensity exercise, phosphocreatine 
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(PCr) and glycogen are depleted  (Lambert & Flynn, 2002; Tesch, Colliander, & Kaiser, 
1986), while H+ and adenosine diphosphate (ADP) accumulate (Miller et al., 1988). 
Resistance exercise confounds the problem since the source of fatigue during the first set 
of 10 repetitions to muscular failure is likely different from the primary source of fatigue 
during the later exercise sets (Lambert & Flynn, 2002). Type II muscle fibers are heavily 
recruited during HRE, especially as greater muscular force is needed to either maintain or 
increase work output (Spiering et al., 2008). The extensive fast glycolysis associated with 
progressive recruitment of type II fibers results in concomitant increases in intracellular 
lactate concentration ([Lac-]) and H+ concentration ([H+]) (Cramer, 2008; Medbo & 
Tabata, 1993). The increasingly acidic intra- and extracellular pH is often implicated as a 
major contributor to skeletal muscle fatigue (Materko et al., 2008; Sahlin et al., 1998). 
Proposed mechanisms of this fatigue suggest that excessive intracellular H+ can reduce 
both actomyosin ATPase activity and the affinity of troponin for calcium (Ca2+), thereby 
reducing actin-myosin coupling and muscular force generating capacity (Allen et al., 
1995; Chin & Allen, 1998; Spriet et al., 1985). Excessive H+ may also interfere with Ca2+ 
release and sequestering by the sarcoplasmic reticulum (Fitts, 1994), reduce sarcolemma 
excitability by enhancing the efflux of potassium (K+) from the cell (Broch-Lips et al., 
2007), and interfere with creatine kinase equilibrium (Sahlin et al., 1998) and 
phosphofructokinase activity (Sutton et al., 1981; Trivedi & Danforth, 1966). 
The presence of a buffer in a system allows for more acid, or H+, to be added to 
that system before affecting a change in pH (Juel, 2008). While several buffer systems 
attenuate elevations in [H+] within the human body, the chemical buffers serve as the first 
line of defense against acidosis, reacting within a fraction of a second to correct acid-base 
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disturbances (Guyton & Hall, 1996). The chemical buffers are comprised of proteins 
(e.g., hemoglobin and albumin), small peptides (e.g., carnosine), dibasic Pi, and 
bicarbonate (Juel, 2008; Sahlin et al., 1978). The bicarbonate system is regarded as the 
most important extracellular buffering system for maintaining acid-base balance (Guyton 
& Hall, 1996) and has been shown to buffer approximately 62% of the H+ released into 
the blood during exhaustive exercise (Medbo et al., 2009). In an effort to enhance the 
extracellular buffer system of athletes performing high-intensity exercise, investigators 
have administered various alkalizing agents, with the most common being sodium 
bicarbonate (NaHCO3) (McNaughton et al., 2008). 
NaHCO3 supplementation to induce alkalosis and enhance exercise performance 
has been in practice for decades (Webster, 2002). Since the bicarbonate ion (HCO3-) does 
not readily permeate the sarcolemma (Mainwood & Cechetto, 1980), the hypothesis for 
the efficacy of such supplementation is that an increase in the extracellular buffering 
capacity facilitates the efflux of H+ from the intracellular compartment (Matson & Tran, 
1993). This, in turn, attenuates the increase in [H+] and consequent fatigue that results 
during high-intensity exercise (McNaughton et al., 2008). While the results of numerous 
NaHCO3 studies are inconsistent, Webster (1993) identified several factors associated 
with consistent performance enhancement. Specifically, ergogenic effects of induced-
alkalosis are strongly associated with continuous exercise protocols resulting in 
exhaustion in one to seven minutes, and those protocols utilizing high-intensity 
intermittent exercise (HIE) (Webster et al., 1993).  HIE studies have demonstrated 
ergogenic effects during cycling (Costill et al., 1984; McKenzie et al., 1986) and 
swimming (Gao et al., 1988; Zajac et al., 2009), as well as various sport-specific tasks 
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(Artioli et al., 2007; Siegler & Hirscher, 2010; Wu et al., 2010). Although several HIE 
studies have investigated the effects of NaHCO3 supplementation on resistance exercise 
performance (Coombes & McNaughton, 1993; Maughan, Leiper, & Litchfield, 1986; 
Verbitsky, Mizrahi, Levin, & Isakov, 1997), only two reported studies have investigated 
the effects of induced-alkalosis on high-volume resistance exercise (Portington et al., 
1998; Webster et al., 1993). 
Webster et al. (1993) first examined the effects of induced-alkalosis on high-
volume resistance exercise utilizing a protocol consisting of four sets of 12 repetitions of 
the leg press exercise at 70% 1-RM, with 90-s of recovery between sets. A fifth set to 
muscular failure with the same load was employed as a performance test. Although four 
of the six participants increased number of performance test repetitions, the results were 
not statistically significant. The relatively minor acid-base perturbation associated with 
the exercise protocol led the authors to suggest that a more intense protocol may be 
necessary to elicit an ergogenic effect (Webster et al., 1993). Portington et al. (1998) took 
this suggestion and conducted a similar study employing a greater exercise intensity. 
Similar to the findings of Webster et al. (1993), seven of the 15 participants increased 
total number of repetitions after induced-alkalosis; however, the results were again not 
statistically significant (Portington et al., 1998). Of important note, neither protocol was 
associated with the severe acid-base disturbances observed in previous studies utilizing 
HIE protocols. Even though the protocols of these resistance exercise studies are 
considered “high-volume”, the utilized volume was still substantially less than that seen 
with typical HRE. For example, Portington et al. (1998) reported that participants 
completed approximately 60 total repetitions throughout the exercise protocol. However, 
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individuals training for muscular hypertrophy often complete 15 to 20 exercise sets per 
muscle group (Lambert & Flynn, 2002). Fifteen exercise sets with a 10-RM load equates 
to 150 total repetitions, representing a 150% increase in the volume used by Portington et 
al. (1998). The greater exercise volume associated with HRE may be more likely to 
create acid-base disturbances similar to that of other HIE modalities. If this is the case, 
then HRE performance may potentially benefit from induced-alkalosis. Therefore, the 
purpose of this study was to examine the effects of NaHCO3 administration during a 
high-volume resistance exercise regimen for the lower body. Furthermore, the exercise 
protocol was designed to mimic real-world hypertropy training, in an effort to elicit 
greater metabolic demands than the protocols of Webster et al. (1993) and Portington et 
al. (1998). 
Methods 
 Participants. Twelve apparently healthy male participants (mean ± SD; age = 
20.3 ± 2 yr, mass = 88.3 ± 13.2 kg, height = 1.80 ± 0.07 m) volunteered to participate in 
this study and provided written informed consent. All participants had been involved in a 
resistance training program utilizing lower body lifts for a minimum of two years. Each 
participant was asked to refrain from his normal lower-body resistance training program 
over the course of the study. Participants were instructed to avoid vigorous exercise 24 
hours prior to all preliminary and experimental exercise testing sessions and to refrain 
from eating for at least three hours prior to each session. This study was approved by The 
University of Southern Mississippi Institutional Review Board for the use of human 
participants in research. 
58 
 
 
 
 Each participant reported to the laboratory on approximately five different 
occasions. Table 2 outlines the study design and procedures.  
Table 2 
Study Design and Procedures 
 
Visit Procedures 
 
1 
 
Informed consent, health history screening, height, weight, and blood pressure 
assessment, familiarization of testing protocol and RM testing 
 
2a Exercise protocol familiarization and determination of baseline performance  
2b Replication of exercise protocol familiarization with performance within ± 10% 
of visit 2a.  If replicated performance variation was greater than ± 10%, an 
additional replication session was performed before progressing to visit 3   
3 Experimental testing: baseline resting blood sample #1 obtained, 
supplementation with NaHCO3 or Placebo, blood sample #2 obtained 50-
min after complete ingestion of the supplement, standardized warm-up, 
squats, leg presses, knee extensions, blood sample #3 obtained upon 
completion of the exercise protocol, knee extension performance test, 
blood sample #4 obtained immediately upon completion of the 
performance test 
4 Experimental testing: Repeat protocol from visit-3 with ingestion of alternate 
supplement 
 
Briefly, on the first visit to the laboratory, each participant engaged in a standardized 
warm-up in preparation for a battery of lifting tests to estimate their repetition 1-RM 
values for various lower-body exercises. The standardized warm-up consisted of pedaling 
on a cycle ergometer (Monark 828E, Monark Exercise AB) for five minutes at a pedal 
cadence of 65 revolutions per minute against a resistance of 1.0 kg. After cycling, each 
participant performed one set of barbell back squats with a weight that easily allowed 
completion of approximately 10 repetitions. After a 120-s rest period, participants 
performed a battery of tests to determine a 3- to 5-RM value for the following exercises: 
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back squat, inclined leg press, and knee extension. The lifting techniques are detailed 
below.  Rest periods of 3-5 min were utilized between RM lifts to allow for adequate 
recovery between attempts (de Salles et al., 2009). From these 3- to 5-RM values, an 
estimated 1-RM value (i.e., the maximal amount of weight that could be lifted one time) 
was calculated utilizing the Epley formula, as follows: 1-RM = (1 + 0.0333 · repetitions) · 
repetition weight (Epley, 1985). This formula provides a valid estimate of the 
participant’s 1-RM for lower body lifts while minimizing the risk of injury from 
excessively heavy loads (Naclerio, Jimenez, Alvar, & Peterson, 2009). This estimated 1-
RM value was subsequently used to assign exercise resistance during the exercise 
protocol. 
Exercise protocol familiarization and determination of baseline performance 
data. The selected exercise protocol was based on a similar, albeit slightly more 
intensive, resistance exercise protocol demonstrated to have a significant impact on 
muscle glycogen metabolism (Tesch, Colliander, & Kaiser, 1986). The protocol was also 
based on the exercise order principle, with multi-joint, large musculature exercises being 
performed first and single-joint exercises being performed last (Baechle et al., 2008). 
Following the standardized warm-up detailed above, the exercises progressed from back 
squats, to inclined leg presses, to knee extensions. Rest intervals throughout the exercise 
protocol ranged from 60 to 120 s, falling within the recommended guidelines for 
maximizing muscular hypertrophy (ACSM, 2009). Each exercise was conducted in 
accordance with the National Strength and Conditioning Association (NSCA) guidelines, 
and all participants were instructed on proper form for all exercises by a Certified 
Strength and Conditioning Specialist. Before progressing to the experimental exercise 
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sessions, the exercise protocol was replicated during familiarization sessions on separate 
days, with the performance (as determined by exercise volume) varying by no more than 
± 10%. Once performance was adequately replicated, participants were progressed to the 
two identical experimental testing sessions, one with administration of the Placebo and 
one with the administration of the Treatment (NaHCO3). 
Back squat—Following the standardized warm-up (as detailed above), each 
participant began the protocol with barbell back squats. Each participant performed four 
sets of back squats, using a load that allowed approximately 10- to12-RM per set. The 
weight was adjusted to allow the necessary repetitions in each set. The approximate 
intensities were as follows: set 1: 75% 1-RM, set 2: 70% 1-RM, set 3: 70% 1-RM, set 4: 
65% 1-RM. The participants rested 90 s between squat sets. Each squat repetition was 
completed in a controlled manner. Each participant lowered the weight until his knees 
were at approximately 90° of flexion and his thighs parallel with the ground.  
Inclined leg press—Following a 120-s recovery period after completion of the last 
back squat set, each participant commenced with the inclined leg press exercise. The 
participants performed four sets of inclined leg presses, again using a load that allowed 
approximately 10- to 12-RM per set. As with the squats, the weight was adjusted to allow 
the necessary repetitions in each set. Each participant rested 90 s between leg press sets. 
Each leg press repetition was completed in a controlled manner, with the weight lifted 
until the knees approached full extension, the weight lowered until the knees were at 
approximately 90° of flexion, and the buttocks remaining in contact with the seat.  
Knee extension—Following another 120-s rest period after completion of the last 
inclined leg press set, each participant commenced with the knee extension exercise. The 
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participants performed four sets of bilateral knee extensions, again using a load that 
allowed approximately 10- to 12-RM per set. As with the previous exercises, the weight 
was adjusted to allow the necessary repetitions in each set. The participants rested 60 s 
between knee extension sets, with the shorter rest interval reflecting the relatively smaller 
musculature involved with the exercise (de Salles et al., 2009). Each knee extension 
repetition was completed in a controlled manner similar to that outlined previously. A 
leather harness, fixated around each participant’s waist and the back pad of the machine, 
was utilized to keep the participant from raising the buttocks off the seat. 
Knee extension performance test—Three minutes after completion of the fourth 
set of knee extensions, participants completed another set of knee extensions utilizing the 
same form; however, this time the load was set at approximately 50% 1-RM, and the 
participant completed as many repetitions as possible to a point of momentary muscular 
failure. 
Experimental testing sessions and supplementation. Each participant performed 
two experimental trials in a randomized, double-blind, counterbalanced fashion. The 
Treatment trial required the participant to consume 0.3 g·kg-1 NaHCO3, while the Placebo 
trial required the participant to consume 0.3 g·kg-1 calcium carbonate (CaCO3). These 
exogenous agents and dosages are consistent with those utilized in previous studies 
(Artioli et al., 2007; Renfree, 2007; Siegler & Hirscher, 2010; Siegler et al., 2009). Both 
the NaHCO3 and Placebo were administered in gelatin capsules (size 00). With ingestion 
of the capsules, the participants consumed a total of approximately1.6 l of fluid. The 
supplement was divided into four equal doses, with each dose consumed at 10-min 
intervals (Matsuura et al., 2007). The first two doses were each consumed with 
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approximately300-ml of a low-sodium, carbohydrate-electrolyte beverage (Gatorade, The 
Gatorade Co.). Also, to minimize potential for GI distress, participants consumed a plain 
bagel during the time allotted for consumption of the first two doses. The second two 
doses were consumed with equal volumes of water (i.e., 500 ml per dose). Dose one was 
consumed 80 min prior to the warm-up, with doses two, three, and four being consumed 
at 70, 60, and 50 min prior to warm-up, respectively. Supplementation was administered 
in this incremental fashion and over a 30-min period in an effort to minimize the potential 
for GI distress, while at the same time peaking blood buffering capacity to coincide with 
the onset of the exercise protocol (Siegler et al., 2009). 
 Blood sampling and analysis. Arterialized capillary blood was collected four 
times during each experimental protocol. To create a hyperemic fingertip, a topical 
vasodilator ointment (Finalgon, Boehringer Ingelheim) was applied to the distal aspects 
of the third and fourth fingers of the left hand. Ten minutes after the application of the 
ointment, the hand and distal forearm were soaked for 10 min in a hot water bath 
maintained at 43-45°C. Immediately upon removal and drying of the hand, the fingertip 
was sterilized with an alcohol wipe and punctured with a one-use safety lancet (21-gauge 
blade; 1.8 mm depth; Prevent, Select Medical Systems). After discarding the initial drop 
of blood, a balanced-heparin capillary tube (115 µL; Safe-T-Fill, Ram Scientific, Inc.) 
was utilized to collect a free-flowing sample within approximately 15 s. The preceding 
protocol was based on a similar blood sampling procedure that has been utilized to obtain 
fingertip specimens that accurately reflect arterial samples (Zavorsky, Lands, Schneider, 
& Carli, 2005). Once the sample was collected and mixed within the capillary tube, 95 µl 
was transferred into a blood gas analysis cartridge (CG4+, Abbott Laboratories) and 
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assessed by a portable clinical analyzer (i-STAT, Abbott Laboratories). The CG4+ 
cartridge analytical panel includes the following variables: pH, bicarbonate concentration 
([HCO3-]), partial pressure of oxygen (PO2), partial pressure of carbon dioxide (PCO2), 
total carbon dioxide (TCO2), saturated oxygen (SO2), base excess (BE), and lactate 
concentration ([Lac-]). The i-STAT analyzer, which was systematically calibrated with 
both a simulator (i-STAT Electronic Simulator, Abbott Laboratories) and known control 
solution (i-STAT Control Level 3, Abbott Laboratories), has been shown to produce 
reliable measures of the above blood gases and analytes across various exercise 
intensities (Dascombe, Reaburn, Sirotic, & Coutts, 2007).     
 The above procedures were replicated for the first two blood samples. The first 
sample (baseline) was collected immediately prior to supplementation. The second 
sample was collected 50 min after ingestion of supplement dose four, just prior to the 
warm-up exercise. Just prior to the incline leg press exercise, the vasodilating ointment 
was reapplied to the third and fourth fingertips of the left hand, allowing the ointment an 
activation period of approximately 10 min before the hand was re-submerged in the water 
bath in preparation for the third blood sample. The third sample was collected 
immediately after the completion of the knee extension exercise, prior to the performance 
test. During the knee extension exercise, the hot water bath was placed adjacent to the 
knee extension machine. To facilitate blood flow, the participant’s left hand/forearm was 
placed into the bath for the duration of the knee extension exercise. Upon completion of 
the fourth set, the participant’s hand was withdrawn from the water, and the third blood 
sample was collected. Immediately following collection of the third sample, the 
participant’s hand/forearm was returned to the hot water bath and remained there 
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throughout the performance test. Upon completion of the performance test, the 
participant’s hand was removed from the bath, and the fourth blood sample was 
collected. 
 Statistical analyses. All values are reported as mean ± SD. All analyses were 
conducted with a statistical software package (SPSS v. 19, SPSS, Inc.). The data were 
analyzed with parametric statistics following confirmation of normal distribution by 
Shapiro-Wilk tests. Repeated-measures ANOVA was utilized to assess the effects of time 
(blood samples one, two, three, and four) and treatment (NaHCO3 and Placebo) on pH, 
[HCO3-], BE, and [Lac-]. Greenhouse-Geisser corrections were utilized when the 
assumption of sphericity was violated. When significant main effects (time, treatment) 
and interactions (time x treatment) were found, post hoc analyses (pair-wise comparisons 
utilizing dependent samples t-tests) were employed to identify where significant 
differences existed within each variable of interest. All exercise performance data were 
analyzed with paired t-tests. The exercise performance variables of interest were total 
squat (SQ) repetitions, total incline leg press repetitions (LP), total knee extension (KE) 
repetitions, total exercise protocol volume (SQ + LP + KE), performance test (PT) 
repetitions, and overall total volume (SQ + LP + KE + PT). Also, to track the effects of 
accumulation of exercise volume, total repetitions for the squat and leg press exercises 
(SQ + LP), as well as for the leg press and knee extension exercises (LP + KE), were 
analyzed. Statistical significance was accepted at P < 0.05.  
Results                                                                                                                                                              
  Blood acid-base parameters. Values for the blood acid-base parameters of interest 
are presented in Table 3. 
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Table 3 
Blood Acid-Base Parameters 
 
                                                                              Blood Sample 
 
Parameter 
 
(1) baseline 
 
(2) 50-min POST 
 
(3) POST EX 
 
(4) POST PT 
 
 
 pH                     
NaHCO3 7.43 ± 0.02 b 7.49 ± 0.02a,b 7.35 ± 0.04a,b 7.35 ± 0.04a,b 
Placebo 7.42 ± 0.02 7.42 ± 0.02 7.28 ± 0.04a 7.30 ± 0.03a,c 
[HCO3-]       (mEq·l-1) 
NaHCO3 26.23 ± 2.11 31.50 ± 2.59a,b 16.80 ± 3.60a,b 17.86 ± 3.63a,b,c 
                  Placebo 25.72 ± 2.25 25.38 ± 1.78 13.81 ± 3.00a 14.79 ± 2.62a,c 
BE                (mEq·l-1)  
NaHCO3 1.92 ± 2.11 7.92 ± 2.57a,b -8.75 ± 4.27a,b -7.67 ± 4.16a,b,c 
                  Placebo 1.33 ± 2.23 1.08 ± 2.11 -12.83 ± 3.38a -11.50 ± 3.29a.c 
[Lac-]           (mEq·l-1) 
NaHCO3 1.00 ± 0.33 1.83 ± 0.33a 17.92 ± 2.08a,b 17.16 ± 2.09a,b,c 
                  Placebo 1.16 ± 0.37 1.68 ± 0.46a 15.55 ± 2.50a 14.92 ± 2.45a,c 
     
 
a—significantly different than baseline       c—significantly different than POST EX  significance accepted at P < 0.05 
b—significantly different than Placebo       values expressed as mean ± SD 
 
 
There were no significant differences in the resting (baseline) values for [HCO3-] (P = 
0.35), BE (P = 0.34), or [Lac-] (P = 0.18) between the NaHCO3 and Placebo conditions; 
baseline pH was higher for the NaHCO3 condition (P < 0.05). At 50-min post-ingestion 
of supplement dose 4 (50-min POST), NaHCO3 administration significantly elevated pH 
(P < 0.05), [HCO3-] (P < 0.05), BE (P < 0.05), and [Lac-] (P < 0.05) above baseline 
values. Placebo administration had no effect on pH (P = 0.18), [HCO3-] (P = 0.37), or BE 
(P = 0.49) at 50-min POST; however, [Lac-] was significantly elevated (P < 0.05). 
Immediately after the exercise protocol (POST EX), pH, [HCO3-], and BE were 
significantly lower than baseline values for both groups (P < 0.05 for all parameters); 
however, the NaHCO3 group values for all POST EX parameters were significantly 
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higher than the placebo POST EX values (P < 0.05 for all parameters). [Lac-] was 
significantly elevated over baseline for both groups POST EX (P < 0.05), with the 
NaHCO3 group demonstrating significantly higher [Lac-] than the placebo group (P < 
0.05). The blood acid-base parameters assessed immediately after the performance test 
(POST PT) followed the same trend as the POST EX data, with all values of pH,   
[HCO3-], and BE being significantly lower than baseline (P < 0.05), and [Lac-] being 
significantly higher than baseline (P < 0.05). The same trend as the POST EX data was 
also evident when comparing group POST PT data, with all parameter values being 
significantly different (P < 0.05) between the NaHCO3 and Placebo conditions. The 
within-group acid-base parameters for blood samples three (POST EX) and four (POST 
PT) significantly differed in terms of Placebo pH (P < 0.05), NaHCO3 and Placebo 
[HCO3-] (P < 0.05 for both conditions), NaHCO3 and Placebo BE (P < 0.05 for both 
conditions), and NaHCO3 and Placebo [Lac-] (P < 0.05 for both conditions).  
Side-effects of supplementation. Supplementation was well tolerated by the 
majority of the participants during the experimental testing procedures. Only one 
participant reported negative side-effects (light-headedness and belching) during the 
exercise protocol following NaHCO3 administration. Two participants in the NaHCO3 
condition reported being nauseated after completion of all experimental testing 
procedures. One participant in the Placebo condition reported nausea acutely after 
cessation of the exercise protocol. 
Exercise performance. Resistance exercise repetitions completed during the 
experimental testing procedures are presented Table 4.  
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Table 4 
Resistance Exercise Repetitions 
 
                                           Supplementation 
Exercise(s) NaHCO3 Placebo Percent Difference 
Between Conditions (%) 
 
SQ (total repetitions) 43.4 ± 5.6 41.8 ± 4.8 
 
3.8 
LP 49.3 ± 8.9 46.3 ± 7.9 6.5 
SQ + LP 92.7 ± 10.0 a 88.1 ± 10.5 5.2 
KE 47.2 ± 5.8 46.3 ± 6.7 1.9 
LP + KE 96.4 ± 11.4 92.7 ± 11.2 4.0 
SQ + LP + KE 139.8 ± 13.2 a 134.4 ± 13.5 4.0 
PT 23.8 ± 4.0 22.3 ± 3.7 6.7 
SQ + LP + KE + PT    163.7 ± 15.1 a 156.7 ± 14.5 4.5 
 
individual exercises presented in order of exercise protocol:  a—significantly greater than Placebo   
SQ—back squats   LP—inclined leg presses  KE—knee extensions significance accepted at P < 0.05    
plus (+) represents accumulation of repetitions over specified exercises  values expressed as mean ± SD, unless specified   
 
Although participants generated more total repetitions per individual exercise (SQ, LP, 
and KE) following NaHCO3 administration, there were no significant differences 
between groups for total repetitions for SQ (P = 0.18), LP (P = 0.06), or KE (P = 0.34). 
However, significant differences became apparent as exercise volume accumulated. For 
example, the NaHCO3 group generated more repetitions than the Placebo group during 
the SQ (43.4 ± 5.6 vs. 41.8 ± 4.8) and LP (49.3 ± 8.9 vs. 46.3 ± 7.9) exercises 
individually, but these differences were not significant. The accumulated repetitions over 
these two exercises (SQ + LP), however, was significantly different between groups 
(NaHCO3 = 92.7 ± 10.0, Placebo = 88.1 ± 10.5, P < 0.05). Along these lines, NaHCO3 
administration also resulted in significantly more total repetitions generated over the 
exercise protocol (SQ + LP + KE; NaHCO3 = 139.8 ± 13.2, Placebo = 134.4 ± 13.5, P < 
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0.05). Performance test (PT) repetitions were not significantly different between groups 
(NaHCO3 = 23.8 ± 4.0, Placebo = 22.3 ± 3.7, P = 0.11). However, overall total volume 
(SQ + LP + KE + PT) was significantly greater following NaHCO3 administration (163.7 
± 15.1 vs. 156.7 ± 14.5, P < 0.05). 
Discussion 
 In the first study examining the effects of NaHCO3 administration on high-
volume resistance exercise, Webster et al. (1993) found that, while four of the six 
participants in the Treatment condition increased repetitions during the performance test, 
there was no significant difference between the NaHCO3 and Placebo groups. Portington 
et al. (1998) followed up this earlier study with a similar, albeit more intensive, protocol 
to assess the Webster et al. (1993) hypothesis that a more intensive resistance training 
regimen may elicit ergogenic effects. Despite the greater exercise intensity (LP: 5 sets x 
~12-RM vs. 4 sets x 12 reps/set at 70% 1-RM, with 5th set to failure), Portington et al. 
(1998) failed to demonstrate ergogenic efficacy for supplementation. The main purpose 
of the present study was to examine the effects of NaHCO3 administration on an even 
more intensive, lower-body resistance exercise protocol, one that more closely mimics a 
regimen designed to elicit hypertrophy. The primary findings of the present study were 
that, in contrast to the previous high-volume resistance exercise studies, supplementing 
with 0.3 g·kg-1 NaHCO3 was an effective means of significantly improving HRE 
performance, allowing for the completion of more accumulated repetitions throughout the 
protocol. Table 5 provides a comparison of the present study to the previous two high- 
volume studies.  
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Table 5 
Comparison of Acid-Base Parameters and Accumulated Repetitions  
Among the High-Volume Resistance Exercise Studies 
 
 
                            POST EX Blood Acid-Base Parameters 
 
    Study 
Repetitions 
(exercise) 
pH 
(units) 
HCO3-
(mEq·l-1) 
BE 
(mEq·l-1) 
 
Lac- 
(mEq·l-1) 
 
 
Webster et 
al. (1993) 
     
    LP = 48  
 
7.25 
 
 
15.4 
 
 
-10.7 
 
 
9.8 
    PT = 18.2  
Total = 66.2 
Portington   
et al. (1998) 
    LP = 60 
~7.25 14.0 -12.3 11.3 Total = 60 
Present 
 
 
   SQ = 41.8 
 
 
7.28 
 
 
13.8 
 
 
-12.8 
 
 
15.6 
   LP = 46.3 
   LE = 46.3 
Total = 134.4  
 
 
values presented are from Placebo trials  POST EX—immediately after exercise protocol  
values expressed as means  
    
 
The present study utilized an exercise regimen that was more prolonged and intense than 
the previous high-volume resistance exercise studies, as evidenced by the fact that the 
protocol of this study elicited substantially greater [Lac-] and resulted in larger declines in 
[HCO3-] and BE (see Table 5). The larger acid-base disturbance is suggestive of a greater 
intracellular to extracellular pH gradient and could explain, at least in part, why NaHCO3 
administration resulted in significant performance improvement in this more prolonged 
protocol. The present study, however, was similar to Portington et al. (1998) in that 
NaHCO3 supplementation failed to elicit ergogenic effects following one multi-set 
exercise involving approximately10- to 12-RM loads. Total repetitions in the present 
study, although higher for the NaHCO3 group, were not significantly different between 
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groups following the first exercise (SQ). However, following the second exercise (LP), 
the accumulated repetitions (SQ + LP) by the NaHCO3 group were significantly greater 
than the Placebo group (92.7 ± 10.0 vs. 88.1 ± 10.5) and represented a 5.2% increase 
from Placebo to NaHCO3 trial. This trend was maintained after the KE exercise, with the 
total resistance exercise volume being significantly higher for the NaHCO3 group (see 
Table 4). Enhanced performance occurring only during the later bouts of exercise is a 
common trend seen with HIE studies (Artioli et al., 2007; Bishop et al., 2004; Gao et al., 
1988; Wahl et al., 2010). Improved performance following a single bout of high-intensity 
exercise is typically not seen under the condition of induced-alkalosis, likely because the 
acid-base disturbances associated with the exercise are not sufficient to establish a strong 
enough pH gradient to substantially facilitate H+ efflux from the cell to the interstitium 
(Matson & Tran, 1993).  This seems to suggest that, had Webster et al. (1993) or 
Portington et al. (1998) utilized a more prolonged exercise protocol, ergogenic efficacy of 
NaHCO3 supplementation may have been demonstrated, as was the case for the present 
study.  
Although the NaHCO3 group performed more PT repetitions (Placebo: 22.3 ± 3.7; 
NaHCO3: 23.8 ± 4.0, representing a 6.7% increase over Placebo trial), there was not a 
significant difference between group means. This is not surprising since, prior to the PT, 
the NaHCO3 group performed significantly more total repetitions throughout the exercise 
protocol (see Table 4). While PT repetitions were not statistically different, overall total 
repetitions (SQ + LP + KE + PT) were a significant 4.5% higher for the NaHCO3 trial. 
This greater volume of work performed during the NaHCO3 trial corresponded to 
significantly higher [Lac-] (17.16 ± 2.09 vs. 14.92 ± 2.45, POST PT), suggesting that 
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greater metabolic demands were associated with the greater work output following 
NaHCO3 administration. Along these lines, several mechanisms accounting for the 
observed significant differences in [Lac-] accompanying exercise under induced-alkalosis 
have been postulated. The greater alkaline state of the NaHCO3 group in the present 
study could have stimulated intramuscular glycolytic flux by upregulating the activity of 
the glycolysis/glycogenolysis regulatory enzymes phosphofructokinase and glycogen 
phosphorylase (Hollidge-Horvat, Parolin, Wong, Jones, & Heigenhauser, 2000; Trivedi 
& Danforth, 1966). An elevation in intracellular [Lac-] could potentially facilitate Lac- 
flux from the muscle cell, ultimately increasing blood [Lac-]. However, Hollidge-Horvat 
et al. (2000) demonstrated that an elevated intracellular [Lac-] likely did not drive Lac- 
efflux, leading the authors to suggest that upregulation of the monocarboxylate lactate 
transporters (Lac-/H+ co-transporters) was potentially responsible for the significantly 
elevated blood [Lac-] following induced-alkalosis. While some research echoes this 
sentiment (Messonnier, Kristensen, Juel, & Denis, 2007), other studies have failed to 
demonstrate enhanced Lac- efflux altogether, leading to the suggestion that the elevated 
[Lac-] is possibly due to reduced Lac- uptake, or clearance from the blood by the body’s 
tissues, rather than enhanced efflux (Raymer, Marsh, Kowalchuk, & Terry, 2004; 
Stephens et al., 2002). While all of the aforementioned mechanisms are plausible, the 
exact cause of elevated [Lac-] following NaHCO3 administration remains to be fully 
elucidated.     
Increases in muscle cross-sectional area represent the principle desired adaptation 
to HRE training. From a practical standpoint, a nutritional supplement would need to 
have the propensity to potentiate muscle growth to warrant its use in conjunction with 
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HRE training. A major finding of the present study is that NaHCO3 administration can 
improve resistance exercise performance, allowing for the completion of more total 
repetitions over the course of a training session. This would seem to suggest that induced-
alkalosis allows for greater training intensity, which could potentially result in greater 
training adaptations (e.g., hypertrophy). However, the literature examining the effects of 
induced-alkalosis on more prolonged training regimens is relatively limited. Edge et al. 
(2006), when examining the effects of eight weeks of sprint training combined with 
NaHCO3 administration, found that induced-alkalosis improved lactate threshold and 
short-term endurance capacity, while resulting in similar improvements in muscle 
buffering capacity as the Placebo group. The investigators concluded that training 
intensity, and not H+ accumulation, was the principle determinant of training adaptations 
(Edge et al., 2006). Given that the degree of muscular hypertrophy following a resistance 
training program is partly dependent upon exercise intensity (Fry, 2004), it stands to 
reason that induced-alkalosis may also elicit favorable training adaptations over the 
course of a resistance training program. However, no studies investigating the effects of 
induced-alkalosis on chronic resistance training have been reported.  
Whether or not greater training intensity translates into greater training 
adaptations depends, at least in part, on hormonal responses to the exercise. Previous 
research has shown that HRE significantly elevates the concentrations of both growth 
hormone ([GH]) and testosterone (Kraemer, Gilgore, Kraemer, & Castracane, 1992; 
Linnamo et al., 2005), with only [GH] being significantly elevated after correcting for 
plasma volume shifts (Kraemer, 1992). In studying the effects of induced-alkalosis on the 
GH response accompanying 90 s of maximal cycling, Gordon et al. (1994) demonstrated 
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that NaHCO3 administration resulted in significantly lower [GH] than placebo 
administration. This led the authors to conclude that H+ may partly be responsible for GH 
stimulation (Gordon et al., 1994). Wahl et al. (2010) conducted a similar study, this time 
investigating the hormonal response to an HIE cycling protocol. The investigators found 
that induced-alkalosis blunted both the GH and cortisol responses, leading to the 
suggestion that acidosis plays a role in the growth and turnover of skeletal muscle. If this 
is the case, then administration of NaHCO3 before HRE may not be advisable, since 
alkalosis may decrease the stimulus for muscle growth.  
Other studies, however, contradict the results of Wahl et al. (2010) and Gordon et 
al. (1994), indicating that pH may not play a significant role in GH stimulation. Sutton et 
al. (1976) administered NaHCO3, ammonium chloride (NH4Cl), or Placebo to examine 
the effects of pH on GH response during cycling at different intensities. The investigators 
found that, while all stages of the variable-intensity cycling protocol increased [GH], 
there was no correlation between pH and GH. Similarly, Elias et al. (1997) found that an 
incremental cycling protocol elevated GH, but there was not a significant difference 
between the NaHCO3 and Placebo treatments. In accordance with the equivocal findings 
of the affects of pH on GH, other mechanisms governing the GH response to exercise 
have been suggested, among those being neural stimulation, nitric oxide production, and 
catecholamine response (Godfrey, Madgwick, & Whyte, 2003). It should also be noted 
that many of the effects of GH are attributed to the downstream mediation of insulin-like 
growth factor I (IGF-I), with minimal contribution from sarcolemmal interaction of GH 
and its receptor (Godfrey et al., 2003). This is important because research has shown that 
induced-alkalosis does not affect the IGF-I response to exercise (Kraemer et al., 1992; 
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Wahl et al., 2010), with some research even demonstrating an increase in [IGF-I] 
following exercise under induced-alkalosis (Kraemer, Harman, Vos, Gordon, Nindl, 
Marx et al., 2000). Also important to note is the fact that the blunted cortisol response 
demonstrated by Wahl et al. (2010) may not be deleterious to training adaptations. 
Tarpenning et al. (2001), utilizing carbohydrate supplementation to blunt the cortisol 
response to resistance exercise, found that attenuation of cortisol levels resulted in 
significant hypertrophy after a 12-week training program. This suggests that induced-
alkalosis may actually enhance, rather than diminish, the muscular hypertrophy 
accompanying HRE. Taken together, the above information warrants further 
investigation into the effects of induced-alkalosis on the adaptations occurring during 
prolonged HRE training.         
In conclusion, NaHCO3 administration in the present study significantly improved 
total accumulated repetitions during a lower-body HRE regimen. These results are in 
contrast to the findings of previous studies examining the effects of induced-alkalosis on 
high-volume resistance exercise. Webster et al. (1993) and Portington et al. (1998) were 
unable to demonstrate significant ergogenic efficacy of NaHCO3 utilizing multiple sets of 
a single lower-body exercise. Since exercise protocols designed to elicit muscular 
hypertrophy typically contain substantially greater volume than that used by the previous 
two “high-volume” studies, the present study sought to employ a more realistic HRE 
regimen, with multiple exercises utilizing four sets of approximately10- to 12-RM loads 
and short rest periods. The greater exercise volume associated with this HRE protocol 
elicited significant metabolic demands, while inducing significant acid-base 
perturbations. This appears to be the combination necessary to demonstrate the ergogenic 
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efficacy of NaHCO3 administration. For supplementation of this nature to be practical for 
real-world use in conjunction with HRE, the enhanced exercise performance must 
translate into enhanced training adaptations. As there have been no reported 
investigations into the effects of induced-alkalosis on chronic resistance training, future 
studies should examine the impact of NaHCO3 administration on the training adaptations 
associated with HRE.    
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APPENDIX A 
INSTITUTIONAL REVIEW BOARD APPROVAL 
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APPENDIX B 
INFORMED CONSENT 
UNIVERSITY OF SOUTHERN MISSISSIPPI 
CONSENT TO ACT AS A HUMAN SUBJECT 
 
Subject’s name:       Date:      
 
Project title:  
 “The effects of sodium bicarbonate supplementation on a hypertrophy-type resistance exercise 
regimen.” 
 
Description and explanation of procedures: 
 You are invited to participate in a research study investigating sodium bicarbonate (i.e. baking 
soda) and its effects on hypertrophy-type (muscle building) resistance exercise for the lower body.  All 
procedures will be conducted in Heidelburg Gymnasium at Belhaven University. The requirements for 
participation as a subject are as follows:  
 
1. Apparently healthy males between 18 and 35 years of age. 
2. Regular participation in a resistance training program involving the lower body for a minimum of 
the past 2 years. 
 
  Approximately 12-15 participants are being recruited for participation in this study and 
representation from all racial and/or ethnic groups will be encouraged. 
 After reading this informed consent, this form will also be read to you by either the principle 
investigator or a research assistant.  At that time, any of your questions or concerns will be addressed by 
either or both of these individuals.  Once written informed consent is provided, you will complete a medical 
history questionnaire and will be measured for height, weight, and blood pressure. If your systolic blood 
pressure is greater than 140 or your diastolic blood pressure is greater than 90, you will be excluded from 
the study.  After these measures are obtained, you will be familiarized with the resistance exercise regimen 
and assessed for 3-5 repetition maximum (RM) lifts on the back squat, inclined leg press, and knee 
extension exercises. After a minimum of 72 hours, you will return to the gymnasium and engage in the full 
exercise regimen. After a minimum of another 72 hours, you will return once again and complete an 
identical protocol. This procedure will be repeated as many times as is necessary for your performance on 
two successive exercise sessions to vary by no more than ± 5-10%. Once your performance is adequately 
replicated, the study will proceed to the experimental trials. During the experimental trials, you will 
complete identical exercise protocols after supplementation with either sodium bicarbonate (baking soda) 
or a calcium carbonate placebo. The amount of supplement that you consume will equate to 0.3 grams per 
kilogram of body weight. For a 70-kilogram (154-pound) person, this would result in the consumption of 
21 grams of the supplement. The supplementation will be contained in gelatin capsules, each containing 
approximately 1 gram of supplement. For the previous example (70-kilogram person), this would lead to 
the consumption of 21 capsules.  
 Sodium bicarbonate supplementation has been shown to induce alkalosis within the blood and 
enhance performance in high-intensity intermittent exercise. This performance enhancement likely occurs 
through the attenuation of the metabolic acidosis that accompanies high intensity exercise. During high 
intensity exercise such as resistance exercise, hydrogen ions accumulate in the active tissues/blood and 
decrease the pH of the intra- and extracellular fluids. A reduction in pH is strongly associated with the 
fatigue experienced during exercise. In order to assess pH and various other analytes, very small blood 
samples will be collected 4 times throughout the experimental exercise trials through a minimally invasive 
technique. A one-use safety lancet will be used to prick the fingertip, and a capillary tube will be utilized to 
collect the sample.     
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 The following is an outline of the protocol: 
  
Visit 1 Informed consent, health history screening, height, weight, 
and blood pressure assessment. Familiarization of testing 
protocol and repetition maximum testing. 
 
Visit 2a Perform the exercise protocol. 
Visit 2b Perform the exercise protocol. 
Visit 2c Perform the exercise protocol until performance with previous 
trials is within ±5-10%. 
 
 Assuming exercise volume is adequately replicated… 
 
 
Visit 3 *Baseline resting blood sample.  
*Supplementation with either sodium bicarbonate or calcium 
carbonate.  
*Blood sample 90 minutes after supplementation.  
*Standardized warm-up. Squats. Leg presses. Knee extensions.  
*Blood sample upon completion of exercise regimen. 
*Knee extension performance test. 
*Blood sample upon completion of performance test. 
Visit 4 Repeat protocol from previous visit with alternate 
supplementation. 
 
Visits will be separated by a minimum of 72 hours to allow for recovery from exercise. 
Time commitment from the participant is approximately 30 minutes for each of Visits 1and 2a,b,c, 
and 3 hours for each of Visits 3 and 4. Approximate total time required is 7.5 hours. 
 
Risks and discomforts: 
 With any exercise there are potential health risks; however, measures will be taken to minimize 
these risks. Some of the possible risks from participation in this study include: 
  1. Abnormal heart responses to the exercise. 
  2. Muscle soreness resulting from the exercise.  
  3. Dizziness, nausea, vomiting, chest pain, heart attack, stroke or death due to 
performing physical exercise. 
  4. Pain associated with fingertip puncture. 
  5. Ill effects due to supplementation. Although baking soda supplementation is 
typically well tolerated, some commonly reported side effects of 
supplementation include bloating, gas, burping, nausea, diarrhea, and light-
headedness. 
   
 Some of the measures taken to prevent or minimize the occurrence of health risks include: 
  1. The researchers are trained in cardiopulmonary resuscitation (CPR) and First 
Aid. The neighboring on-call athletic training staff is trained in emergency 
management. 
  2. At least one Certified Strength and Conditioning Specialist will always be on 
hand to ensure proper lifting and spotting techniques. 
  3. Large volumes of water will be consumed with the supplementation to reduce 
the likelihood of gastrointestinal discomfort. Over 1.5 liters of fluid will be 
consumed with supplementation in order to dilute the baking soda. Participants 
will also be encouraged to continue to drink fluids throughout the exercise 
regimen to maintain the dilution. The supplement will also be administered in 
smaller doses taken over a period of time to further reduce the potential for 
gastrointestinal distress.  
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 Neither the University of Southern Mississippi nor Belhaven University has a mechanism to 
provide you compensation if you incur injuries as a result of participation in this research project.  
However, efforts will be made to make available the facilities and professional skills of the research staff. 
Mr. Ben Carr will either be present or on call at all times should a research-related injury or illness occur.  
Should you experience such a problem, please call Ben Carr at (601) 421-2195 (cell) or (601) 968-8964 
(office). In the event that you are unable to reach Ben Carr, you may also call Dr. Don Berryhill at (601) 
974-6458 (office) or the Belhaven Athletic Training staff at (601) 968- 8789. In the event that it is 
determined that you need the attention of a physician, you will be referred to either your personal 
physician, the physician at the Belhaven clinic, or one of the local emergency rooms.  Any of these 
physicians will be available to you, but there will be a fee involved in use of their services.  This is a 
double-blind study, which means that neither the researcher nor you will know to which group you have 
been assigned.  Upon completion of the study, you will be informed as to which group you were assigned.  
In the event of a medical emergency, or you request that this information be divulged, the code will be 
broken prior to completion of the study.  However, this will necessitate that you discontinue participation in 
the study. 
 
Potential benefits: 
 As a participant in this study, you will receive knowledge about your body’s 
physiological responses to common resistance training exercises. You will also receive 
information about your repetition maximums for common resistance exercises, as well as guidance 
in techniques to achieve maximum muscular hypertrophy. The results of this study may provide 
insight into a relatively inexpensive method of maximizing work output during a resistance 
training regimen, thereby potentiating muscle growth. For your participation, you will be 
compensated $50. You will receive $10 after completion of the first experimental testing session, 
with the remaining $40 being provided upon completion of the last testing session. 
 
Confidentiality: 
All data will be dealt with using a numerical code to identify you, the participant.  The 
coding will only be known by the investigators. Individual participant information will only be 
released upon written request to the principle investigator by the participant, or in the event of a 
medical emergency, by the participant’s physician. All data will be on file in the office of the 
principle investigator, and only the principle investigator or assistant will be allowed to examine 
the data collected on the participant. Only group data will be disclosed upon completion and 
publication of this investigation. Data will be kept on file in the office of the principle investigator 
for three years, after which time all data will be destroyed. 
 
Consent: 
 Information about the procedures described above and the possible risks and benefits of the project 
have been explained.  Whereas no assurance can be made concerning results that may be obtained, the 
researcher will take every precaution consistent with the best scientific practice.  Questions concerning the 
research should be directed to Ben Carr (601) 968-8964 (office) or (601) 421-2195 (cell). This project and 
this consent form have been reviewed by the Human Subjects Protection Review Committee, which 
ensures that research projects involving human participants follow federal regulations.  Any questions or 
concerns about rights as a research subject should be directed to the Director of Research and Sponsored 
Programs, University of Southern Mississippi, Box 5157, Hattiesburg, MS 39406,  
(601)-266-4119. 
 Participation in this project is completely voluntary, and you are free to withdraw at any time 
without penalty or prejudice, or loss of benefits.  In addition, all personal information is strictly confidential 
and no names will be disclosed.  During the course of the study, your information will be identified by a 
letter-number combination.  Any new information that might develop during the course of the project will 
be provided to you if that information might affect your willingness to participate in the project. 
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Consent to participate in this project is hereby given by the undersigned.  A copy of this form has 
been given to me. 
 
 
             
Date   Subject’s signature  
   
 
             
Date   Signature of Researcher explaining the study 
 
 
             
Date   Witness  
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APPENDIX C 
DEBRIEFING FORM 
Adverse Reaction Information 
Thank you for your participation in this research study. While every precaution will be taken to provide an 
injury- and illness-free experience, you should be aware of potential adverse reactions related to nutritional 
supplementation. With almost any supplementation regimen, there is the inherent risk of unpleasant side 
effects. Sodium bicarbonate supplementation is usually well-tolerated—meaning individuals rarely report 
adverse reactions to the supplement. However, due to the relatively large amount of the supplement that 
will be consumed during the experimental testing session of this study, you should be aware of potential 
side effects. Most reported adverse effects of sodium bicarbonate supplementation involve the 
gastrointestinal track. These symptoms include gas, bloating, cramping, diarrhea, and nausea. Most of these 
symptoms, while uncomfortable, are manageable and do not typically preclude individuals from 
participating in the research. These adverse effects are likely due to the concentrated sodium load imposed 
on the gut by the supplementation. In order to minimize the potential for adverse effects, a large volume of 
fluid will be consumed with the supplementation. Also, in an effort to reduce the load on the 
gastrointestinal track, the supplement will be divided into four doses, consumed over a period of 30 
minutes.  
In the event that you do experience an adverse reaction, that reaction will likely be short-lived. If you start 
feeling ill in the time period after the exercise protocol, drinking cold water, lying down, and/or applying a 
cold compress to your head may help alleviate symptoms. If you start feeling ill before or during the 
exercise protocol, please notify the researcher or assistants immediately. Every effort will be made to help 
you manage any negative side effects. Mr. Ben Carr will either be present or on call at all times should a 
research-related injury or illness occur.  Should you experience such a problem, please call Ben Carr at 
(601) 421-2195 (cell) or (601) 968-8964 (office). In the event that you are unable to reach Mr. Carr, you 
may also call Dr. Don Berryhill at (601) 974-6458 (office) or the Belhaven Athletic Training staff at (601) 
968- 8789. In the event that it is determined that you need the attention of a physician, you will be referred 
to either your personal physician, the physician at the Belhaven clinic, or one of the local emergency 
rooms.  Any of these physicians will be available to you, but there will be a fee involved in use of their 
services. 
Always keep in mind that your participation is completely voluntary. If you experience an adverse reaction 
and choose to no longer participate in the study, then that is certainly your prerogative. Your wellbeing is a 
top priority to the researcher and assistants. 
 
I have been fully debriefed and the researcher and/or research assistant has offered to answer any and all of 
my questions related to this research study. 
Print Name_____________________________________ 
Sign Name _____________________________________ 
Date____________ 
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APPENDIX D 
HEALTH HISTORY AND PHYSICAL ACTIVITY QUESTIONNAIRE 
Belhaven University 
Department of Sports Medicine & Exercise Science 
 
In conjunction with the University of Southern Mississippi 
 
Pre-Participation Health Screening and Risk Stratification Form 
 
Information you provide will be treated as personal and confidential. This information will enable 
us to better understand your health status and fitness habits. The intent of this form is not to treat 
or diagnose any illnesses, but rather to evaluate your risk for an adverse exercise- or 
supplementation-related event. Please direct any questions pertaining to this form to laboratory 
personnel. Do not put your name on this form. 
 
Subject ID Number         Date   
(NOT your SSN; will be provided by researcher)                (mm/dd/yyyy) 
 
Age  Gender   Height      Weight           Race   
 
 
Section I.  Known Cardiovascular, Pulmonary, and Metabolic Disease 
 
 
Have you ever had (or currently have) any of the following? Circle “yes” or “no” for each 
disease: 
 
a. Cardiovascular Disorders 
 
Cardiovascular disease (CVD)   Yes No 
 
Angina (chest pain)     Yes No 
 
Peripheral artery disease (PAD)   Yes No 
 
Hypertension (high blood pressure)   Yes No 
 
Cerebrovascular disease    Yes No 
 
Heart clicks (abnormal heart sounds)  Yes No 
 
Stroke      Yes No 
 
Heart murmur     Yes No 
 
Coronary artery disease (CAD)   Yes No 
 
Emboli (abnormal blood particles)   Yes No 
Heart attack     Yes No 
83 
 
 
 
Heart surgery     Yes No 
 
Angioplasty (surgical opening of a heart artery) Yes No 
  
Phlebitis (inflammation of a vein)   Yes No   
 
Anemia      Yes No 
 
b. Pulmonary Disorders 
 
Chronic obstructive pulmonary disease (COPD) Yes No 
 
Asthma      Yes No 
 
Interstitial lung disease (tissues surrounding lung) Yes No 
 
Cystic fibrosis     Yes No 
 
Emphysema (lung disease)    Yes No 
 
Bronchitis (lung inflammation)   Yes No 
 
c. Metabolic Disorders 
 
Diabetes (type 1 or type 2)    Yes No 
 
Thyroid disorders     Yes No 
 
Renal (kidney) or hepatic (liver) disease  Yes No    
 
d. Other Disorders 
 
Cancer      Yes No 
Emotional disorders     Yes No 
Eating disorders     Yes No 
Osteoporosis (decreased bone mass/density)  Yes No 
Epilepsy      Yes No 
Gastrointestinal disorders    Yes No 
Stomach ulcers     Yes No  
Digestive disorders     Yes No  
 
e. Do you have ANY disorders or problems not listed above? Yes No 
 
If you answered “yes” please provide details:       
 
f. Do you know of or suspect ANY reason (medical, health, or otherwise) why you should not 
participate in this study?      Yes No 
 
If you answered “yes” please provide details:       
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Section II.  Major Signs and Symptoms Suggestive of Cardiovascular, Pulmonary, and 
Metabolic Disease 
 
Have you ever experienced any of the following? Circle “yes” or “no” for each sign or symptom: 
 
Yes No 1.  Pain, discomfort, tightness, or numbness in the chest, neck, jaw, or arms 
 
Yes No 2.  Shortness of breath at rest or with mild exertion 
 
Yes  No 3.  Dizziness or fainting 
 
Yes  No 4.  Difficult, labored, or painful breathing during the day or at night 
 
Yes  No  5.  Ankle swelling 
 
Yes No 6.  Rapid pulse or heart rate (palpitations) 
 
Yes  No 7.  Intermittent muscle cramping 
 
Yes No 8.  Known heart murmur 
 
Yes No 9.  Unusual fatigue or shortness of breath with usual activities 
 
If you answered “YES” to any of the above: 
  
How often do you experience the sign or symptom?        
 
Have you ever discussed the sign or symptom with a doctor?  Yes No 
 
Please explain the sign or symptom in more detail:        
 
             
 
 
 
 
Section III. Atherosclerotic Cardiovascular Disease Risk Factors 
 
 
Yes No 1.  Are you ≥ 45 years old (if male) or ≥ 55 years old (if female)? 
 
Yes No 2.  Has your father or brother experienced a heart attack (or cardiovascular 
surgery) before the age of 55, or has your mother or sister experienced a 
heart attack (or cardiovascular surgery) before the age of 65? 
 
Yes  No 3. Do you currently smoke, have quit smoking within the past 6 months, or 
are regularly exposed to environmental tobacco smoke (e.g. second-hand 
smoke)? 
 
Yes No 4.   Do you have a “sedentary” lifestyle? (less than 30 minutes of 
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moderate intensity physical activity less than 3 days per week) 
Yes No 5.   Do you have a body mass index (BMI) ≥ 30, waist girth > 102 cm (> 39 
in.) if male, or waist girth > 88 cm (> 35 in.) if female? (measured and 
indicated to you by the investigator) 
 
Yes No 6.   Has your medical doctor ever told you that you have high blood pressure 
(hypertension) or are you on medication to control your blood pressure? 
 
Yes No 7.   Has your medical doctor ever told you that you have high blood 
cholesterol (hypercholesterolemia) or are you on medication to control 
your cholesterol? 
        
        Total cholesterol:   HDL:   Date Tested:   
 
Yes No 8.   Has your medical doctor ever told you that you have an “impaired” or 
high fasting blood glucose level (measurement of blood glucose taken 
after you have not eaten for 12-14 hours) or impaired glucose tolerance 
following an oral glucose tolerance test (OGTT) (measurement of blood 
glucose taken after consuming a sugary drink or slice of bread)? 
 
 
 
Section IV. Questions Relating Specifically to the Present Research Study 
[The Effects of Sodium Bicarbonate Supplementation on Lower-Body 
Hypertrophy-Type Resistance Exercise] 
 
 
a. General Safety 
 
 
Yes No 1.   Do you have arthritis or any bone or joint problem? 
   If yes, please explain:        
 
Yes  No 2.   Are you taking any medications? 
Name them and their dosage (both prescribed and over-the-counter 
medications) 
             
 
Yes  No 3.   Do you currently take a multivitamin? 
 
Yes        No          4.   Do you currently take any kind of performance-enhancing supplement 
(e.g. creatine, HMB, androstenedione, etc)? 
 If so, what are you taking? ________________________________ 
 
Yes No 5.  Do you use drugs of any kind? 
 
Yes No  6. Do you currently use tobacco of any kind? 
 
Yes No 7. Has your weight been unstable for the past month? 
Yes  No 8.   Are you on a collegiate athletic team? 
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Yes No 9. Have you had any signs and symptoms of illness or within the past seven 
days? 
 
Yes No 10. Have participated in a resistance training program for a minimum of the 
past two years? 
 
 
b. Physical Activity, Training, and Injury Status 
 
 
A. Do you currently participate in resistance exercise (e.g. weightlifting)? Yes No 
 
B. How many times per week do you participate in resistance exercise? ________________  
 
C. In general, what is your training goal? ________________________________________ 
 
D. On average, how long do you participate in resistance exercise per exercise session? 
_______________________________________________________________________ 
 
 
E. What type of resistance exercises do you perform? 
_______________________________________________________________________ 
 
F. Are you currently injured? 
 
 Yes   No 
 
If yes what is the nature of your injury:        
 
G. Have you suffered an injury to your lower limbs or lower back in the last 6 months? 
 
 Yes   No 
 
If yes what was the nature of your injury:        
 
H. Are you currently suffering from any symptoms of gastrointestinal distress (e.g. nausea, 
cramping, diarrhea, etc.)? 
 
 Yes   No 
 
If yes what symptoms are you experiencing?:       
 
I. Do you know of any reasons why you should not participate in this research study? 
 
 Yes   No 
 
If yes please state the reason:          
 
J. How frequently do you consume caffeinated beverages?:      
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By checking the box below I certify that all of the above is true, to the best of my knowledge. 
 
Check here   Date:     
 
 
END OF FORM 
 
LABORATORY USE ONLY 
 
 
ACSM Risk Stratification Summary 
 
Section I 
Known or diagnosed disease?   Yes No [if yes exclude from study] 
 
Section II 
Major signs or symptoms?   Yes No [if yes exclude from study] 
 
Section III 
Number of cardiovascular risk factors: 0 1 >1 [if  > 1 exclude from study] 
 
 
Risk Stratification (circle one): Low Risk Moderate Risk  High Risk 
 
Other 
 
Resting blood pressure:    Resting Heart Rate:    
 
Do medications affect BP or HR?  Yes   No 
 
Date:     Staff initials:    
 
Physical Activity, Exercise, and Training Criteria for the Present Research Study 
[The Effects of Echinacea-Induced Erythropoietin Production on Erythropoiesis, Oxygen 
Transport, and Exercise Capacity] 
 
Does the prospective research participant meet the training criteria, “recreationally trained”, for 
this investigation? Yes No 
(Recreationally trained for this investigation will consist of performing cardiorespiratory 
exercise 3-5 days·week-1, 20-60 minutes·session-1, at 40% and 50% to 85% VO2R or HRR, or 64% 
and 70% to 94% of HRmax (American College of Sports Medicine [ACSM] Guidelines for 
Exercise Testing and Prescription) 
 
Comments 
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MEDICAL DOCTOR REFERRAL FORM  
(Only provided to “Moderate Risk” or “High Risk” Participants) 
 
 
ACSM Risk Stratification Summary 
 
Section I 
Known or diagnosed disease?  Yes No  [if yes exclude from study] 
 
Section II 
Major signs or symptoms?  Yes No  [if yes exclude from study] 
 
Section III 
Number of cardiovascular risk factors: 0 1 >1 [if  > 1 exclude from study] 
 
Risk Stratification (assigned by researcher): Low Risk     Moderate Risk High Risk 
 
 
The Risk Stratification process assigns participants into one of three risk categories: 
“Low Risk”, “Moderate Risk”, and “High Risk”. 
 
The “Low Risk” classification is assigned to individuals who: (a) do not have any 
signs/symptoms of cardiovascular, pulmonary, and/or metabolic disease, (b) do not have a 
diagnosed cardiovascular, pulmonary, and/or metabolic disease, and (c) have no more than one 
(i.e., ≤ 1) cardiovascular disease risk factor. All three of these requirements must be met for a 
“Low Risk” classification. For individuals classified as “Low Risk”, the risk of an acute 
cardiovascular event is low. Therefore, a physical activity and/or exercise program may be 
followed safely without the need for a medical examination, physician clearance, or physician 
supervision (1). 
 
The “Moderate Risk” classification is assigned to individuals who: (a) do not have 
signs/symptoms of cardiovascular, pulmonary, and/or metabolic disease, (b) do not have a 
diagnosed cardiovascular, pulmonary, and/or metabolic disease, but (c) have two or more (i.e., ≥ 
2) cardiovascular disease risk factors. For individuals classified as “Moderate Risk”, the risk of an 
acute cardiovascular event is increased. Most individuals who are classified as “Moderate Risk” 
may safely perform low- to moderate-intensity physical activities and/or exercise without the 
need for a medical examination, physician clearance, or physician supervision. Before “Moderate 
Risk” individuals participate in vigorous-intensity exercise, it is recommended to have a medical 
examination, an exercise test, and physician supervision of the exercise test (1). 
 
The “High Risk” classification is assigned to individuals who: (a) have one or more 
signs/symptoms of cardiovascular, pulmonary, and/or metabolic disease, or (b) have one or more 
diagnosed cardiovascular, pulmonary, and/or metabolic disease. For individuals classified as 
“High Risk”, the risk of an acute cardiovascular event is increased to the degree that requires a 
thorough medical examination to take place and physician clearance is required before this 
population can begin physical activity or exercise at any intensity (low-, moderate-, or vigorous-
intensity) (1). 
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1. American College of Sports Medicine (ACSM). American College of Sports Medicine’s 
Guidelines for Exercise Testing and Prescription. 8th edition. Lippincott Williams & 
Wilkins, Baltimore, MD; 2010. 
 
Signatures: 
 
I, the undersigned, have understood the explanation by the researcher of the risk 
stratification process that assigns individuals into one of three risk categories: (a) “Low Risk”, (b) 
“Moderate Risk”, or (3) “High Risk”. The signing of this form indicates that I have understood 
the medical referral by the researcher based on the assigned risk category of “Moderate Risk” to 
consult my physician or other appropriate health care provider before engaging in vigorous-
intensity exercise and/or exercise testing; or the assigned risk category of “High Risk” to consult 
my physician before engaging physical activity or exercise of any intensity. I understand that the 
risk stratification process is simply a screening process, and is not intended as an attempt by the 
researchers to diagnose or treat any disease or medical conditions. 
 
 
__________________________________                    __________________________________ 
Signature of Participant                 Date  Signature of Researcher                 Date  
 
__________________________________   __________________________________ 
Name of Participant (print)  Name of Researcher (print) 
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APPENDIX E 
DATA COLLECTION SHEETS 
Visit 1 
Data Sheet 
Subject Number: ________      Date: _____________ 
 
Exercise Attempt # Weight (lbs) Repetitions to Failure 
Squat   1 _________  _________ 
Settings 2 _________  _________ 
Rack:  3 _________  _________ 
Rails:  4 _________  _________ 
   5 _________  _________ 
_______________________________________________________ 
Leg Press  1 _________  _________ 
   2 _________  _________ 
   3 _________  _________ 
   4 _________  _________ 
   5 _________  _________ 
_______________________________________________________ 
Knee Ext  1 _________  _________ 
Settings  2 _________  _________ 
Back:  3 _________  _________ 
Ankle:  4 _________  _________ 
   5 _________  _________ 
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Visit 2a 
Data Sheet 
 
Subject Number: ________      Date: _____________ 
 
Exercise Est 1RM (lbs) %1RM Weight (lbs) Plates/side Set # RM   
Squat  ______  75 _____    1 _____ 
90 sec b/t sets   70 _____    2 _____  
    70 _____    3 _____  
    65 _____    4 _____ 
*2-minute rest*      Total Reps: _____   
Leg Press ______  65 _____    1 _____ 
90 sec b/t sets   65 _____    2 _____  
    60 _____    3 _____  
    60 _____    4 _____ 
*2-minute rest*      Total Reps: _____   
Knee Ext ______  70 _____  Machine  1 _____ 
60 sec b/t sets   70 _____    2 _____  
    65 _____    3 _____  
    65 _____    4 _____ 
*3-minute rest*      Total Reps: _____   
Knee Ext PT ______  50 _____     _____ 
 
Total Volume (pre PT): _____ reps 
Overall Total Volume:   _____ reps 
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Visit 2b(c, if needed) 
Data Sheet 
Subject Number: ________      Date: _____________ 
 
Exercise Est 1RM (lbs) %1RM Weight (lbs) Plates/side Set # RM   
Squat  ______  ____ _____    1 _____ 
90 sec b/t sets   ____ _____    2 _____  
    ____ _____    3 _____  
    ____ _____    4 _____ 
*2-minute rest*      Total Reps: _____   
Leg Press ______  ____ _____    1 _____ 
90 sec b/t sets   ____ _____    2 _____  
    ____ _____    3 _____  
    ____ _____    4 _____ 
*2-minute rest*      Total Reps: _____   
Knee Ext ______  ____ _____  Machine  1 _____ 
60 sec b/t sets   ____ _____    2 _____  
    ____ _____    3 _____  
    ____ _____    4 _____ 
*3-minute rest*      Total Reps: _____   
Leg Ext PT ______  50 _____     _____ 
 
Total Volume (pre PT): _____ reps 
Overall Total Volume:   _____ reps 
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Visit 3 (or 4) 
Data Sheet 
Supplementation: _______ Subject Number: ________  Date: _____________ 
 
Exercise Est 1RM (lbs) %1RM Weight (lbs) Plates/side Set # RM   
Squat  ______  ____ _____    1 _____ 
90 sec b/t sets   ____ _____    2 _____  
    ____ _____    3 _____  
    ____ _____    4 _____ 
*2-minute rest*      Total Reps: _____   
Leg Press ______  ____ _____    1 _____ 
90 sec b/t sets   ____ _____    2 _____  
    ____ _____    3 _____  
    ____ _____    4 _____ 
*2-minute rest*      Total Reps: _____   
Knee Ext ______  ____ _____  Machine  1 _____ 
60 sec b/t sets   ____ _____    2 _____  
    ____ _____    3 _____  
    ____ _____    4 _____ 
*3-minute rest*      Total Reps: _____   
Knee Ext PT ______  50 _____     _____ 
 
                                                                                          Total Volume (pre PT): _____ reps 
            Overall Total Volume:   _____ reps 
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Visit 3 (or 4) Continued 
Data Sheet 
 
Blood Sample—Ref Values  
Temp:  37 ºC 
pH:  7.35-7.45 
PCO2:  35-45 mm Hg 
PO2:  75-100 mm Hg 
HCO3:  22-26 mEq/l 
O2 sat:  92-100 % 
BE: 0 ± 3 mEq/l 
 
 
 
Blood Sample—Baseline 
Temp:  _____ ºC 
pH:  _____ 
PCO2:  _____ mm Hg 
PO2:  _____ mm Hg 
O2 sat: _____ %  
HCO3:  _____ mEq/l 
TCO2:  _____ mEq/l 
BE:  _____ mEq/l 
Lac:  _____ mM 
 
 
 
 
 
 
 
 
 
 
Blood Sample—2 
Temp:  _____ ºC 
pH:  _____ 
PCO2:  _____ mm Hg 
PO2:  _____ mm Hg 
O2 sat: _____ % 
HCO3:  _____ mEq/l 
TCO2:  _____ mEq/l 
BE:  _____ mEq/l 
Lac:  _____ mM 
Blood Sample—3 
Temp:  _____ ºC 
pH:  _____ 
PCO2:  _____ mm Hg 
PO2:  _____ mm Hg 
O2 sat: _____ % 
HCO3:  _____ mEq/l 
TCO2:  _____ mEq/l 
BE:  _____ mEq/l 
Lac:  _____ mM 
Blood Sample—4 
Temp:  _____ ºC 
pH:  _____ 
PCO2:  _____ mm Hg 
PO2:  _____ mm Hg 
O2 sat: _____ % 
HCO3:  _____ mEq/l 
TCO2:  _____ mEq/l 
BE:  _____ mEq/l 
Lac:  _____ mM 
  
 
 
APPENDIX F 
SUBJECT RAW DATA 
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APPENDIX G 
STATISTICAL ANALYSES 
Dependent Samples t-tests for Performance Data 
 
Paired Differences    
Mean SD SEM t df Sig. (2-tailed) 
Pair 1 NaHCO3 Squat (SQ) Reps   
Plac SQ Reps 
1.66667 4.05268 1.16991 1.425 11 .182 
Pair 2 NaHCO3 Leg Press (LP) 
Reps Plac LP Reps 
2.91667 4.88892 1.41131 2.067 11 .063 
Pair 3 NaHCO3 SQ + LP  
Plac SQ + LP 
4.58333 5.72805 1.65355 2.772 11 .018 
Pair 4 NaHCO3 Knee Ext (KE) Reps 
Plac KE Reps 
.83333 2.88675 .83333 1.000 11 .339 
Pair 5 NaHCO3 LP + KE  
Plac LP + KE 
3.75000 6.42615 1.85507 2.021 11 .068 
Pair 6 NaHCO3 SQ + LP + KE   
Plac SQ + LP + KE 
5.41667 6.89477 1.99035 2.721 11 .020 
Pair 7 NaHCO3 Perf Test (PT) Reps  
Plac PT Reps 
1.58333 3.17543 .91667 1.727 11 .112 
Pair 8 NaHCO3 SQ + LP + KE + PT 
Plac SQ + LP + KE + PT 
7.00000 8.14639 2.35166 2.977 11 .013 
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Repeated Meaures ANOVA and Post Hoc Testing for Blood Acid-Base Data 
Parameter: pH Type III SS df Mean Square F Sig. 
Time Sphericity Assumed .335 3 .112 168.114 .000 Greenhouse-Geisser .335 1.382 .242 168.114 .000 
Trial Between Treatments .053 1 .053 27.490 .000 
Time * Trial Sphericity Assumed .015 3 .005 7.570 .000 Greenhouse-Geisser .015 1.382 .011 7.570 .005 
 
 
   Paired Samples Post Hoc Test 
Parameter: pH df t Sig.  Parameter: pH df t Sig.  
Pair 1 pH_BS1_NaHCO3 pH_BS2_NaHCO3 
11 -8.710 .000 Pair 9 pH_BS1_plac pH_BS4_plac 11 10.654 .000 
Pair 2 pH_BS1_NaHCO3 pH_BS3_NaHCO3 
11 6.799 .000 Pair 10 pH_BS2_plac pH_BS3_plac 11 9.319 .000 
Pair 3 pH_BS1_NaHCO3 pH_BS4_NaHCO3 
11 5.734 .000 Pair 11 pH_BS2_plac pH_BS4_plac 11 9.059 .000 
Pair 4 pH_BS2_NaHCO3 pH_BS3_NaHCO3 
11 12.670 .000 Pair 12 pH_BS3_plac pH_BS4_plac 11 -3.625 .004 
Pair 5 pH_BS2_NaHCO3 pH_BS4_NaHCO3 
11 10.763 .000 Pair 13 pH_BS1_ NaHCO3 pH_BS1_plac 11 1.091 .299 
Pair 6 pH_BS3_NaHCO3 pH_BS4_NaHCO3 
11 -1.688 .119 Pair 14 pH_BS2_ NaHCO3 pH_BS2_plac 11 9.177 .000 
Pair 7 pH_BS1_plac - pH_BS2_plac 11 1.420 .183 Pair 15 
pH_BS3_ NaHCO3 
pH_BS3_plac 11 8.803 .000 
Pair 8 pH_BS1_plac - pH_BS3_plac 11 10.747 .000 Pair 16 
pH_BS4_ NaHCO3 
pH_BS4_plac 11 7.716 .000 
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Parameter: HCO3- Type III SS df Mean Square F Sig. 
Time 
Sphericity Assumed 3200.247 3 1066.749 297.573 .000 
Greenhouse-Geisser 3200.247 1.269 2520.973 297.573 .000 
Trial Between Treatments 241.300 1 241.300 12.090 .002 
Time * Trial Sphericity Assumed 94.859 3 31.620 8.820 .000 Greenhouse-Geisser 94.859 1.269 74.724 8.820 .004 
 
 
   Paired Samples Post Hoc Test 
Parameter: HCO3- df t Sig.  Parameter: HCO3- df t Sig.  
Pair 1 HCO3_BS1_NaHCO3 HCO3_BS2_NaHCO3 
11 
-10.966 .000 Pair 9 HCO3_BS1_plac HCO3_BS4_plac 
11 12.141 .000 
Pair 2 HCO3_BS1_NaHCO3 HCO3_BS3_NaHCO3 
11 9.678 .000 Pair 10 HCO3_BS2_plac HCO3_BS3_plac 
11 13.552 .000 
Pair 3 HCO3_BS1_NaHCO3 HCO3_BS4_NaHCO3 
11 8.626 .000 Pair 11 HCO3_BS2_plac HCO3_BS4_plac 
11 13.040 .000 
Pair 4 HCO3_BS2_NaHCO3 HCO3_BS3_NaHCO3 
11 15.210 .000 Pair 12 HCO3_BS3_plac HCO3_BS4_plac 
11 -4.346 .001 
Pair 5 HCO3_BS2_NaHCO3 HCO3_BS4_NaHCO3 
11 14.333 .000 Pair 13 HCO3_BS1_ NaHCO3 HCO3_BS1_plac 
11 .984 .346 
Pair 6 HCO3_BS3_NaHCO3 HCO3_BS4_NaHCO3 
11 -7.557 .000 Pair 14 HCO3_BS2_ NaHCO3 HCO3_BS2_plac 
11 11.805 .000 
Pair 7 HCO3_BS1_plac - HCO3_BS2_plac 
11 .939 .368 Pair 15 HCO3_BS3_ NaHCO3 HCO3_BS3_plac 
11 6.449 .000 
Pair 8 HCO3_BS1_plac - HCO3_BS3_plac 
11 13.205 .000 Pair 16 HCO3_BS4_ NaHCO3 HCO3_BS4_plac 
11 6.655 .000 
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Parameter: BE Type III SS df Mean Square F Sig. 
Time 
Sphericity Assumed 4330.208 3 1443.403 271.377 .000 
Greenhouse-Geisser 4330.208 1.256 3446.680 271.377 .000 
Trial Between Treatments 352.667 1 352.667 15.214 .001 
Time * Trial Sphericity Assumed 117.750 3 39.250 7.379 .000 Greenhouse-Geisser 117.750 1.256 93.724 7.379 .008 
 
 
   Paired Samples Post Hoc Test 
Parameter: BE df t Sig.  Parameter: BE df t Sig.  
Pair 1 BE_BS1_NaHCO3 BE_BS2_NaHCO3 
11 
-10.392 .000 Pair 9 BE_BS1_plac BE_BS4_plac 11 11.455 .000 
Pair 2 BE_BS1_NaHCO3 BE_BS3_NaHCO3 
11 8.922 .000 Pair 10 BE_BS2_plac BE_BS3_plac 11 12.764 .000 
Pair 3 BE_BS1_NaHCO3 BE_BS4_NaHCO3 
11 8.186 .000 Pair 11 BE_BS2_plac BE_BS4_plac 11 11.397 .000 
Pair 4 BE_BS2_NaHCO3 BE_BS3_NaHCO3 
11 15.014 .000 Pair 12 BE_BS3_plac BE_BS4_plac 11 -4.690 .001 
Pair 5 BE_BS2_NaHCO3 BE_BS4_NaHCO3 
11 14.672 .000 Pair 13 BE_BS1_ NaHCO3 BE_BS1_plac 11 1.000 .339 
Pair 6 BE_BS3_NaHCO3 BE_BS4_NaHCO3 
11 -4.168 .002 Pair 14 BE_BS2_ NaHCO3 BE_BS2_plac 11 10.922 .000 
Pair 7 BE_BS1_plac - BE_BS2_plac 11 .713 .491 Pair 15 
BE_BS3_ NaHCO3 
BE_BS3_plac 11 7.000 .000 
Pair 8 BE_BS1_plac - BE_BS3_plac 11 12.881 .000 Pair 16 
BE_BS4_ NaHCO3 
BE_BS4_plac 11 6.993 .000 
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Parameter: Lac- Type III SS df Mean Square F Sig. 
Time 
Sphericity Assumed 5391.352 3 1797.117 1080.283 .000 
Greenhouse-Geisser 5391.352 1.109 4862.610 1080.283 .000 
Trial Between Treatments 352.667 1 352.667 15.214 .001 
Time * Trial Sphericity Assumed 32.261 3 10.754 6.464 .001 Greenhouse-Geisser 32.261 1.109 29.097 6.464 .015 
 
 
   Paired Samples Post Hoc Test 
Parameter: Lac- df t Sig.  Parameter: Lac- df t Sig.  
Pair 1 Lac_BS1_NaHCO3 Lac _BS2_NaHCO3 
11 -5.327 .000 Pair 9 Lac _BS1_plac     Lac _BS4_plac 11 -19.585 .000 
Pair 2 Lac _BS1_NaHCO3 Lac _BS3_NaHCO3 
11 -29.425 .000 Pair 10 Lac _BS2_plac     Lac _BS3_plac 11 -21.024 .000 
Pair 3 Lac_BS1_NaHCO3 Lac _BS4_NaHCO3 
11 
-27.650 .000 Pair 11 Lac _BS2_plac     Lac _BS4_plac 11 -20.526 .000 
Pair 4 Lac _BS2_NaHCO3 Lac _BS3_NaHCO3 
11 
-26.808 .000 Pair 12 Lac _BS3_plac     Lac _BS4_plac 11 5.073 .000 
Pair 5 Lac _BS2_NaHCO3 Lac _BS4_NaHCO3 
11 -25.798 .000 Pair 13 Lac _BS1_ NaHCO3             Lac _BS1_plac 11 -1.436 .179 
Pair 6 Lac _BS3_NaHCO3 Lac _BS4_NaHCO3 
11 4.965 .000 Pair 14 Lac _BS2_ NaHCO3 Lac _BS2_plac 11 1.171 .266 
Pair 7 Lac _BS1_plac    Lac _BS2_plac 11 -3.465 .005 Pair 15 
Lac _BS3_ NaHCO3              
Lac _BS3_plac 11 8.347 .000 
Pair 8 Lac _BS1_plac    Lac _BS3_plac 11 -20.162 .000 Pair 16 
Lac _BS4_ NaHCO3 
Lac _BS4_plac 11 7.908 .000 
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